Mood disorders

KRA_PSY_MOOD

mood disorder: A cognitive disorder a disturbance in which the person's mood is hypothesized to be the main underlying feature.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F30-F39 Hospital discharge: ICD-9 — 296\|3004A\|3011D Hospital discharge: ICD-8 — 296\|29800\|3004\|30110 Cause of death: ICD-10 — F30-F39 Cause of death: ICD-9 — 296\|3004A\|3011D Cause of death: ICD-8 — 296\|29800\|3004\|30110 2 out of 7 registries used, show all original rules.	68435
4. Check minimum number of events None	68435
5. Include endpoints None	68435
6. Filter based on genotype QC (FinnGen only)	68435

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_MOOD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F3
HD_ICD_9	296\|3004A\|3011D
HD_ICD_8	296\|29800\|3004\|30110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F3
COD_ICD_9	296\|3004A\|3011D
COD_ICD_8	296\|29800\|3004\|30110
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mood disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	68435	45643	22792
Unadjusted period prevalence (%)	13.72	15.56	10.05
Median age at first event (years)	40.20	38.33	43.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
42520: Matched controls
305157

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.5

323.0

777

495

A02BC03

ATC

lansoprazole; oral

1.7

323.0

11744

56326

F60.9

ICD-10 Finland

Personality disorder, unspecified

46.8

323.0

1249

197

F40.1

ICD-10 Finland

Social phobias

16.2

323.0

1601

736

SPAT1243

SPAT

Psychiatric/psychological examination

7.8

323.0

1511

1443

P72

ICPC

Schizophrenia

6.6

323.0

1185

1327

K02.1

ICD-10 Finland

Caries of dentine

1.7

323.0

22756

121591

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.9

323.0

1407

2099

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

670.5

323.0

2633

N03AG01

ATC

valproic acid; systemic, rectal

9.6

323.0

5466

4607

N06AB04

ATC

citalopram; systemic

8.0

323.0

18807

27381

N06AB03

ATC

fluoxetine; oral

7.3

323.0

10641

13398

T36

ICD-10 Finland

Poisoning by systemic antibiotics

19.4

323.0

4551

1869

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

323.0

10904

52388

R42

ICD-10 Finland

Dizziness and giddiness

1.8

323.0

8179

36058

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

323.0

6203

25350

N05BA01

ATC

diazepam; systemic, rectal

4.8

323.0

9652

17555

C07AA05

ATC

propranolol; systemic

2.8

323.0

9715

28853

N03AE01

ATC

clonazepam; systemic

5.2

323.0

3977

5960

N06BA04

ATC

methylphenidate; oral

7.5

323.0

995

975

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

323.0

28458

161261

F31.8

ICD-10 Finland

Other bipolar affective disorders

276.1

323.0

1851

F60.5

ICD-10 Finland

Anankastic personality disorder

38.5

323.0

884

168

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

323.0

9846

46414

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

37.2

323.0

4780

1034

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

323.0

6604

26107

N06AX18

ATC

reboxetine; oral

14.9

323.0

985

485

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

141.8

323.0

9612

627

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

820.5

323.0

1650

SPAT1240

SPAT

Therapeutic discussion

6.0

323.0

6852

9401

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

9.7

323.0

859

644

F10.20

ICD-10 Finland

Alcohol dependence currently independent

15.9

323.0

2056

970

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

323.0

6824

28538

N05AL01

ATC

sulpiride; systemic

11.3

323.0

1273

830

P99

ICPC

Psychological disorders other

14.0

323.0

2196

1185

WX290

NOMESCO Finland

Other blockade of nerve

1.7

323.0

17392

86513

KMAK

NOMESCO Finland

1.6

323.0

19970

108803

P06

ICPC

Sleep disturbance

3.0

323.0

4629

12078

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.9

323.0

1372

1724

F32.8

ICD-10 Finland

Other depressive episodes

34.8

323.0

1273

270

M79.7

ICD-10 Finland

Fibromyalgia

5.0

323.0

1686

2485

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

323.0

852

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.6

323.0

1967

3188

N05CF01

ATC

zopiclone; oral

3.5

323.0

18974

56523

N06AA09

ATC

amitriptyline; systemic

4.1

323.0

6402

12745

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

323.0

11564

56468

N03AX12

ATC

gabapentin; oral

2.5

323.0

7497

23766

A06AD11

ATC

lactulose; oral

2.3

323.0

6220

20910

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

292.1

323.0

2101

N05AD01

ATC

haloperidol; systemic

5.2

323.0

1813

2600

F41.09

ICD-10 Finland

UNS Panic Syndrome

7.3

323.0

1457

1481

N05BA02

ATC

chlordiazepoxide; systemic

7.4

323.0

1835

1848

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4026.0

323.0

561

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.9

323.0

2333

1480

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

13.8

323.0

884

469

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.9

323.0

6289

12945

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

323.0

22378

125372

N05AA02

ATC

levomepromazine; systemic

13.0

323.0

4267

2603

N05AA01

ATC

chlorpromazine; systemic, rectal

9.7

323.0

1087

822

SPAT1307

SPAT

Psychosocial counselling and guidance

5.9

323.0

2882

3722

F33

ICD-10 Finland

Recurrent depressive disorder

19.5

323.0

1273

482

H03AA01

ATC

levothyroxine sodium; systemic

1.8

323.0

8872

39321

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

8.6

323.0

865

738

N05CF02

ATC

zolpidem; oral

2.9

323.0

9469

27257

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

13641

60320

N06AX21

ATC

duloxetine; oral

6.7

323.0

8633

11137

R03AC02

ATC

salbutamol; inhalant

1.6

323.0

20421

110772

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

30.4

323.0

544

130

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

323.0

3664

10654

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.9

323.0

3902

10445

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

79.0

323.0

1292

121

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.7

323.0

1137

864

F22.0

ICD-10 Finland

Delusional disorder

7.9

323.0

1020

942

P16

ICPC

Acute alcohol abuse

6.9

323.0

1029

1096

F51.0

ICD-10 Finland

Nonorganic insomnia

3.4

323.0

6694

15879

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

323.0

3086

8983

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.1

323.0

1453

1067

N05AF03

ATC

chlorprothixene; systemic

14.6

323.0

2624

1372

M25.5

ICD-10 Finland

Pain in joint

1.6

323.0

10634

51943

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

323.0

563

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

16.8

323.0

1611

713

WX110

NOMESCO Finland

Local anesthesy

1.7

323.0

27746

158100

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

18.0

323.0

945

385

F99

ICD-10 Finland

Mental disorder, not otherwise specified

15.0

323.0

1561

775

F39

ICD-10 Finland

Unspecified mood [affective] disorder

55.9

323.0

1489

198

N06AA06

ATC

trimipramine; systemic

8.1

323.0

1878

1730

F33.8

ICD-10 Finland

Other recurrent depressive disorders

73.9

323.0

619

N05AN01

ATC

lithium; oral

38.2

323.0

2775

557

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

60.9

323.0

717

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

323.0

11375

54177

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

8.6

323.0

1011

864

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

323.0

1329

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

24.7

323.0

3556

1125

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

323.0

11160

49885

M79.6

ICD-10 Finland

Pain in limb

1.7

323.0

13971

67912

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

125.3

323.0

2266

137

R53

ICD-10 Finland

Malaise and fatigue

2.5

323.0

9154

30280

SPAT1301

SPAT

No procedures

1.6

323.0

11748

58033

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

26.5

323.0

571

157

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

323.0

8305

37396

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

17.7

323.0

633

260

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

323.0

5917

21926

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

323.0

612

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

10.6

323.0

7523

6090

R06.0

ICD-10 Finland

Dyspnoea

1.8

323.0

9594

42368

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

19.4

323.0

993

376

F32.0

ICD-10 Finland

Mild depressive episode

8.6

323.0

1560

1340

F43.1

ICD-10 Finland

Post-traumatic stress disorder

11.9

323.0

1191

734

F61.0

ICD-10 Finland

Mixed personality disorders

51.8

323.0

1830

265

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

513.1

323.0

1453

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.9

323.0

1507

869

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

591.0

323.0

1588

N05AC02

ATC

thioridazine; oral

8.2

323.0

1499

1352

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

27.9

323.0

2323

631

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.8

323.0

2653

7189

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

323.0

775

Z71.8

ICD-10 Finland

Other specified counselling

1.9

323.0

8941

38257

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

323.0

5629

22221

F10.24

ICD-10 Finland

Alcohol depence active use

12.3

323.0

1251

748

F32

ICD-10 Finland

Depressive episode

10.2

323.0

4021

3086

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

+∞

323.0

390

S06.0

ICD-10 Finland

Concussion

2.3

323.0

4268

14341

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

323.0

1718

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.5

323.0

1422

2351

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

74.3

323.0

3526

371

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

290.3

323.0

601

V03AA01

ATC

7.1

323.0

1196

1243

N05AB03

ATC

perphenazine; systemic, rectal

11.3

323.0

3323

2263

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

30.2

323.0

879

213

N07BB01

ATC

disulfiram; oral

7.9

323.0

3894

3862

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

102.5

323.0

494

N06AX03

ATC

mianserin; oral

10.0

323.0

4483

3568

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

323.0

5774

16880

L17

ICPC

Foot/toe symptom/complaint

1.7

323.0

9445

43956

N05AH03

ATC

olanzapine; systemic

15.6

323.0

6487

3474

SPAT1234

SPAT

Support of social functional capacity

3.2

323.0

2227

5161

AA400

NOMESCO Finland

Electroconvulsive therapy

81.4

323.0

834

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

22.9

323.0

583

185

IGY99

NOMESCO Finland

Other psychiatric treatment contact

26.6

323.0

1328

370

L03

ICPC

Low back symptom/complaint

1.9

323.0

9393

39939

F90.0

ICD-10 Finland

Disturbance of activity and attention

7.0

323.0

1105

1153

N05BA12

ATC

alprazolam; oral

4.8

323.0

7235

12396

N05BA04

ATC

oxazepam; oral

5.5

323.0

17716

35115

N02BE01

ATC

paracetamol; systemic, rectal

1.8

323.0

34686

217723

A04

ICPC

Weakness/tiredness general

2.4

323.0

5048

16517

P03

ICPC

Feeling depressed

8.6

323.0

6291

6011

N06AX12

ATC

bupropion; oral

16.5

323.0

5827

2900

N03AF01

ATC

carbamazepine; oral, rectal

3.3

323.0

2608

5927

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

323.0

11741

52788

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

323.0

1944

4425

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

6.3

323.0

2311

2766

F41.00

ICD-10 Finland

Moderate panic disorder

15.8

323.0

1010

469

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

323.0

15975

85124

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

16.0

323.0

8921

4975

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

323.0

19490

100628

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

323.0

24789

141821

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

16211

80977

P29

ICPC

Psychological sympt/compl other

7.6

323.0

3701

3788

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.8

323.0

3803

10358

N05BA06

ATC

lorazepam; systemic, sublingual

6.4

323.0

3719

4482

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

323.0

16583

89606

F34.1

ICD-10 Finland

Dysthymia

68.5

323.0

4328

504

AA1AD

NOMESCO Finland

CT of head and brain

1.9

323.0

9818

41040

N06AX05

ATC

trazodone; oral

12.8

323.0

2082

1220

N06AX17

ATC

milnacipran; oral

14.0

323.0

911

478

SPAT1254

SPAT

Administration of medicine

2.0

323.0

5705

21648

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

89.2

323.0

4587

413

N05AX12

ATC

aripiprazole; systemic

18.2

323.0

3501

1493

N05BE01

ATC

buspirone; oral

12.8

323.0

2707

1614

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

10.7

323.0

1094

750

P01AB01

ATC

metronidazole; oral, rectal

1.6

323.0

14659

77010

N05CD07

ATC

temazepam; oral

4.8

323.0

8878

15856

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.1

323.0

5613

6362

A02BC05

ATC

esomeprazole; systemic

1.5

323.0

15671

84046

F32.1

ICD-10 Finland

Moderate depressive episode

18.8

323.0

4966

2131

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

209.4

323.0

6337

255

N06AG02

ATC

moclobemide; oral

8.7

323.0

3886

3505

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

151.6

323.0

6851

386

-1

NOMESCO Finland

1.6

323.0

12527

62447

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

28.9

323.0

1138

290

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

26.7

323.0

863

237

F41.8

ICD-10 Finland

Other specified anxiety disorders

7.0

323.0

1161

1211

N06AX26

ATC

vortioxetine; oral

10.8

323.0

4613

3405

G47.3

ICD-10 Finland

Sleep apnoea

2.0

323.0

9578

39343

P15

ICPC

Chronic alcohol abuse

6.8

323.0

2060

2253

N05AB01

ATC

dixyrazine; systemic

9.4

323.0

937

731

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

309.0

323.0

2254

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

9.2

323.0

5600

4941

N03AX09

ATC

lamotrigine; oral

16.1

323.0

4204

2068

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

323.0

3270

9423

N03AX16

ATC

pregabalin; oral

2.6

323.0

12032

40241

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

323.0

11319

50072

R51.80

ICD-10 Finland

Headache

2.4

323.0

6032

19734

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

27.5

323.0

755

200

P74

ICPC

Anxiety disorder/anxiety state

9.8

323.0

2159

1650

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

183.1

323.0

850

N06AB05

ATC

paroxetine; oral

7.3

323.0

4884

5364

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

323.0

22373

120371

F31

ICD-10 Finland

Bipolar affective disorder

117.2

323.0

1191

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

26.2

323.0

1939

556

F60.7

ICD-10 Finland

Dependent personality disorder

72.5

323.0

420

F29

ICD-10 Finland

Unspecified nonorganic psychosis

12.4

323.0

3287

2052

E66.8

ICD-10 Finland

Other obesity

3.0

323.0

2211

5422

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

296.8

323.0

3266

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

30.1

323.0

1243

305

G44.2

ICD-10 Finland

Tension-type headache

2.1

323.0

4991

18177

A02BC02

ATC

pantoprazole; systemic

1.7

323.0

26299

148468

F60.8

ICD-10 Finland

Other specific personality disorders

43.0

323.0

545

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

78.2

323.0

442

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

28.1

323.0

1829

486

N05AD03

ATC

melperone; systemic

7.3

323.0

869

866

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

9.9

323.0

6093

5092

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

323.0

9750

42642

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

323.0

14362

62924

N06AB10

ATC

escitalopram; oral

7.1

323.0

15598

23095

N05AX08

ATC

risperidone; systemic

7.4

323.0

6291

7022

L28

ICPC

Limited function/disability (L)

2.0

323.0

5917

23265

IGY02

NOMESCO Finland

Psychiatric monitoring contact

22.0

323.0

1732

588

P76

ICPC

Depressive disorder

14.7

323.0

5435

3005

N06AB08

ATC

fluvoxamine; oral

9.0

323.0

2284

1902

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.3

323.0

1356

1583

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

76.0

323.0

11137

1415

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

111.1

323.0

2590

178

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

21.6

323.0

1112

379

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

1211.6

323.0

1278

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.0

323.0

2262

5582

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

8.4

323.0

1328

1168

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

23.7

323.0

1369

428

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

323.0

6638

28249

EBA00

NOMESCO Finland

Extraction of tooth

1.8

323.0

13356

61501

N06AA04

ATC

clomipramine; systemic

8.7

323.0

1295

1102

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

94.4

323.0

1052

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.4

323.0

971

681

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

26.6

323.0

2124

603

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.7

323.0

1286

1662

N06AB06

ATC

sertraline; oral

9.1

323.0

9531

9382

N06AX11

ATC

mirtazapine; oral

6.8

323.0

24092

49189

N06AX16

ATC

venlafaxine; oral

12.1

323.0

14064

11996

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

323.0

7736

33693

A02BC01

ATC

omeprazole; systemic

1.7

323.0

10701

50371

F32.9

ICD-10 Finland

Depressive episode, unspecified

56.8

323.0

17554

3727

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

17885

87804

N04AA02

ATC

biperiden; systemic

7.9

323.0

1448

1347

N06AX22

ATC

agomelatine; oral

17.4

323.0

1662

710

N05AH02

ATC

clozapine; systemic

6.5

323.0

1253

1414

N05AH04

ATC

quetiapine; oral

12.3

323.0

16541

15022

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

323.0

6051

24753

N06AA12

ATC

doxepin; systemic

6.5

323.0

4190

5023

F41.1

ICD-10 Finland

Generalized anxiety disorder

14.6

323.0

3377

1795

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

323.0

14489

74393

J01DA01

ATC

[U] cefalexin; systemic

1.5

323.0

24510

145002

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

66.4

323.0

2286

261

N05AF01

ATC

flupentixol; systemic

10.3

323.0

1295

931

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2605.8

323.0

1084

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

685.1

323.0

1026

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

323.0

20868

112956

P01

ICPC

Feeling anxious/nervous/tense

6.5

323.0

5665

7058

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

37.4

323.0

844

165

A01

ICPC

Pain general/multiple sites

2.5

323.0

3147

9428

D11

ICPC

Diarrhoea

2.2

321.6

3983

13960

SPAT1263

SPAT

Sampling

1.5

317.5

15507

83503

A02BA02

ATC

ranitidine; systemic

1.7

317.3

7692

34498

SPAT1310

SPAT

Counselling related to known health issue

1.6

315.6

11645

58634

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

19.8

314.4

530

194

J02AC01

ATC

fluconazole; systemic

1.5

312.1

13734

72119

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

311.8

17713

98516

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

310.6

5027

19642

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.5

310.1

822

804

R74

ICPC

Upper respiratory infection acute

1.6

310.0

9453

45243

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

310.0

4229

15439

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

16.8

309.5

552

239

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.1

308.9

686

494

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

307.2

3385

11230

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

20.9

306.9

509

177

P25

ICPC

Phase of life problem adult

3.8

306.3

1474

2869

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

306.0

5742

23664

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

61.5

303.4

399

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

53.6

303.2

407

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

20.9

302.2

501

174

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

301.8

6790

29697

188

Kela drug reimbursment

Psychosis requiring demanding treatment

8.4

301.7

743

645

F43.29

ICD-10 Finland

Adaptation disorder UNS

5.5

300.5

994

1317

F61

ICD-10 Finland

Mixed and other personality disorders

30.4

297.1

445

106

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

296.7

14936

80611

IBA03

NOMESCO Finland

Psychotherapy evaluation

46.6

295.6

406

R02

ICPC

Shortness of breath/dyspnoea

2.0

295.3

4409

16675

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

292.6

14157

75667

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

270.3

292.2

338

N01

ICPC

Headache

2.2

291.3

3355

11351

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

291.1

16644

92230

P27

ICPC

Fear of mental disorder

10.3

291.0

640

452

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

289.9

8797

41922

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

289.7

5564

23073

L01

ICPC

Neck symptom/complaint

1.9

289.4

4905

19459

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

8.4

287.9

708

613

M03BX02

ATC

tizanidine; oral

1.5

286.5

23944

143219

WZA90

NOMESCO Finland

Other doctors statement

1.6

285.7

8514

40347

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

9.4

285.3

659

511

N06AA22

ATC

14.5

284.2

536

269

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

281.7

10024

49726

R52.2

ICD-10 Finland

Other chronic pain

3.5

281.1

1500

3178

F41.3

ICD-10 Finland

Other mixed anxiety disorders

10.4

279.7

613

430

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

20.5

279.4

466

165

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.1

278.4

1759

4226

N03AX11

ATC

topiramate; oral

4.6

278.4

1076

1698

F30.9

ICD-10 Finland

Manic episode, unspecified

328.3

278.1

319

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

32.9

278.1

409

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

278.0

6188

26899

SPAT1216

SPAT

Assessment of functional ability

1.8

275.3

5495

23048

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

273.2

3801

13947

C07AB07

ATC

bisoprolol; oral

1.5

272.8

17377

98021

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

32.6

272.1

401

A28

ICPC

Limited function/disability NOS

1.8

270.7

5168

21346

N05CD02

ATC

nitrazepam; oral

5.2

270.6

949

1346

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

270.5

8353

39879

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

269.8

2893

9448

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

13.3

269.2

525

286

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.3

269.0

1548

3475

J01DB01

ATC

cefalexin; oral

1.5

268.7

32052

204674

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

268.1

7104

32502

P73

ICPC

Affective psychosis

32.4

267.0

394

IEY01

NOMESCO Finland

Psychoeducation, individual

22.7

266.1

430

137

R21

ICPC

Throat symptom/complaint

1.7

265.4

6148

27018

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

265.2

12096

63450

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

13.2

263.4

516

284

Z01.2

ICD-10 Finland

Dental examination

1.5

260.7

14791

81240

Z08

ICPC

Social welfare problem

7.1

260.6

716

739

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

260.6

8441

40749

P28

ICPC

Limited function/disability (P)

11.3

260.3

547

352

N06AA10

ATC

nortriptyline; systemic

4.4

258.9

1065

1790

N05AE04

ATC

ziprasidone; systemic

20.2

258.0

432

155

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

257.1

4281

16822

R11

ICD-10 Finland

Nausea and vomiting

2.2

255.8

2871

9575

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

42.2

254.7

356

IGV01

NOMESCO Finland

Psychiatric network contact

15.7

254.2

464

214

Z72.1

ICD-10 Finland

Alcohol use

6.5

253.8

739

829

F21

ICD-10 Finland

Schizotypal disorder

14.9

253.7

472

229

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

10.0

253.4

565

410

SPAT1260

SPAT

Consultation of another employee

1.7

253.2

6382

28722

R06AE07

ATC

cetirizine; oral

1.5

252.7

15796

88309

SPAT1283

SPAT

Restricted health certificate

1.8

249.8

5303

22633

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

15.9

249.5

453

206

N05AF05

ATC

zuclopenthixol; systemic

7.1

249.5

681

696

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

673.5

249.4

280

L02

ICPC

Back symptom/complaint

2.1

249.3

3228

11471

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

249.1

7261

34030

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.5

247.6

820

1087

R52.9

ICD-10 Finland

Pain, unspecified

2.1

247.6

3158

11149

R4140

NOMESCO Finland

Psychotherapy

24.7

246.5

389

114

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

245.9

9923

50436

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

245.5

3022

10503

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

243.4

14168

77913

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

24.0

242.1

385

116

P80

ICPC

Personality disorder

32.9

238.0

350

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

237.0

13742

75397

F34.0

ICD-10 Finland

Cyclothymia

110.6

237.0

291

SPAT1241

SPAT

Extensive assessment of psychosocial situation

7.9

236.8

602

551

29800

ICD-8 Finland

Other psychoses, Reactive depressive psychosis

+∞

236.6

259

IHZ05

SPAT

6.0

236.5

732

891

D01

ICPC

Abdominal pain/cramps general

2.0

234.4

3551

13436

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

233.1

8025

39179

K59.0

ICD-10 Finland

Constipation

2.5

232.6

2097

6254

R05

ICPC

Cough

1.6

231.9

7618

36748

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

231.7

8977

45085

F60.0

ICD-10 Finland

Paranoid personality disorder

41.2

231.6

325

T90

ICPC

Diabetes non-insulin dependent

1.6

231.2

8345

41204

UJF32

NOMESCO Finland

Coloscopy

1.5

228.6

9380

47713

R03BB04

ATC

tiotropium bromide; inhalant

2.0

228.1

3555

13590

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

25.4

226.8

355

101

SPAT1238

SPAT

Brief therapy

5.5

226.0

753

1005

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

225.1

3572

13746

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.3

224.4

665

764

T82

ICPC

Obesity

3.0

224.0

1436

3477

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

222.9

10293

53701

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

53.9

222.4

298

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

22.9

222.2

358

113

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

221.5

2217

6978

M79.1

ICD-10 Finland

Myalgia

1.8

220.6

4395

18318

M01AE02

ATC

naproxen; oral, rectal

1.4

220.1

20927

125291

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

219.1

9720

50234

F43.00

ICD-10 Finland

Acute stress reaction mild

4.1

218.7

956

1702

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.5

218.3

861

1386

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

218.3

2852

10148

J01FF01

ATC

clindamycin; systemic

1.5

218.2

9915

51504

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

217.7

3866

15488

A10BA02

ATC

metformin; oral

1.5

216.2

9805

50889

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

22.4

215.9

350

113

Z00.0

ICD-10 Finland

General medical examination

1.6

215.7

6475

30442

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

215.3

4087

16754

H02AB06

ATC

prednisolone; systemic

1.4

214.8

17016

98478

SPAT1312

SPAT

General health counselling

1.5

214.8

10909

57983

P98

ICPC

Psychosis NOS/other

11.6

213.8

442

275

R07.3

ICD-10 Finland

Other chest pain

1.9

213.5

3467

13443

P18

ICPC

Medication abuse

15.2

212.9

393

187

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

212.8

2169

6885

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

18.4

212.2

366

144

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

211.4

1647

4515

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

211.3

5440

24505

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

210.9

2271

7404

N02AA05

ATC

oxycodone; systemic

1.7

210.2

5082

22476

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.4

210.1

857

1427

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

31.0

210.1

313

IER01

NOMESCO Finland

Psychoeducation, group

24.5

210.0

332

P58

ICPC

Psychological, Therapeutic counselling/listening

5.9

209.9

655

806

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

4.7

209.7

791

1215

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

209.4

5630

25669

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

208.6

4366

18467

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

207.8

4478

19114

N07BA03

ATC

varenicline; oral

2.4

207.6

2058

6440

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

11.3

207.4

434

277

F30.0

ICD-10 Finland

Hypomania

162.0

207.4

247

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

207.1

5872

27157

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

207.0

6133

28700

Z73.0

ICD-10 Finland

Burn-out

3.7

205.4

1017

2022

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

205.3

1676

4723

S18

ICPC

Laceration/cut

1.4

205.3

15145

86311

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

205.2

3890

15921

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6922

27749

1.72

323.31

2.4

2.3

0.2

g/l

7.44

6294

25972

(3014111) Lactate [Moles/volume] in Serum or Plasma

6426

25386

1.74

315.98

7.0

7.2

1.4

1.3

mmol/l

2.26

6114

24542

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6642

26587

1.71

311.38

4.2

3.9

5.9

5.8

kpa

9.38

6378

25853

(3002032) Base excess in Venous blood by calculation

6622

26491

1.72

311.09

4.3

3.9

1.9

1.8

mmol/l

0.61

5391

21772

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9313

40763

1.59

307.84

2.7

2.6

22.2

23.2

8.06

7975

34898

(3019550) Sodium [Moles/volume] in Serum or Plasma

58677

340700

2.56

307.65

18.9

14.0

139.5

139.7

mmol/l

56.17

57469

331728

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

48760

246689

2.25

307.65

8.0

7.2

76.8

77.0

u/l

0.37

46080

232457

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

34595

162121

1.87

307.65

6.0

10.0

11.4

umol/l

78.23

32400

153606

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15166

70957

1.53

307.65

1.9

1.7

1.1

1.2

mg/l

3.57

11138

53781

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9730

37942

1.81

307.65

6.0

1.0

mmol/l

0.87

9073

35464

(3018010) Neutrophils/100 leukocytes in Blood

31651

156906

1.64

307.65

6.6

5.8

56.7

57.0

5.48

29519

147495

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

20845

90271

1.77

307.65

2.4

2.0

230.1

204.7

u/l

1.80

19591

84784

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

2229

314

48.26

307.65

12.2

12.0

0.6

mmol/l

0.87

2065

278

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12845

52451

1.76

307.65

2.6

3.1

2.4

mmol/l

21.28

11063

45894

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7549

26418

1.99

307.65

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1648

836

13.26

307.65

1.9

2.0

—

(3026008) Bacteria identified in Urine by Culture

19524

91752

1.57

307.65

3.3

2.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

42203

227755

1.64

307.65

4.9

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22745

115330

1.46

307.65

4.0

3.2

44.6

61.9

ng/l

1.36

14090

73035

(3013650) Neutrophils [#/volume] in Blood by Automated count

38120

187929

1.82

307.65

10.5

8.7

4.2

4.1

e9/l

11.88

33258

164871

(3044889) 12 lead EKG panel

40803

223335

1.55

307.65

3.9

3.4

—

(3006315) Basophils [#/volume] in Blood

34069

162818

1.80

307.65

6.6

5.8

0.0

e9/l

1.93

29401

141984

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

23078

98045

1.85

307.65

3.0

2.5

55.1

58.6

u/l

10.68

21179

90633

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

57401

341389

2.00

307.65

17.2

12.5

21.0

23.1

mg/l

45.09

47095

265826

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

54921

319659

1.90

307.65

5.0

4.1

6.0

5.8

mmol/l

70.05

50913

294420

(3015736) pH of Urine

25762

124537

1.60

307.65

3.8

3.2

5.9

5.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

59087

361110

1.96

307.65

18.7

14.3

74.0

75.9

umol/l

32.27

59077

360916

(3022096) Basophils/100 leukocytes in Blood

30399

148201

1.66

307.65

6.7

6.0

0.7

2.10

28259

138705

(1001926) Buprenorphine [Presence] in Urine by Screen method

6364

9229

4.92

307.65

3.0

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

17259

79754

1.58

307.65

4.4

3.8

94.2

91.0

50.46

16703

77770

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

56266

307068

2.67

307.65

6.1

4.4

1.9

2.1

mu/l

2.39

52852

283397

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1299

1194

7.27

307.65

3.1

2.5

38.2

24.2

ug/l

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

51322

255482

2.61

307.65

5.0

3.8

14.4

14.7

pmol/l

163.85

47511

233331

(3032080) INR in Blood by Coagulation assay

23523

122595

1.41

307.65

8.0

8.2

1.1

1.2

inr

22.44

7153

36210

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

7718

31827

1.67

307.65

1.9

1.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

41104

214886

1.71

307.65

5.3

4.1

1636.6

1309.4

e6/l

0.50

572

2861

(36304419) Bacteria [Presence] in Urine

18006

83835

1.57

307.65

3.3

2.9

—

(4198724)

1408

842

11.21

307.65

2.3

—

(3021589) Normoblasts [#/volume] in Blood

28822

145459

1.55

307.65

10.3

9.1

0.0

e9/l

1.77

23422

119966

(3042517) Benzodiazepines panel - Urine

429

141

20.11

307.65

2.9

3.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1391

2117

4.39

307.65

1.7

1.3

1.5

1.4

promille

1.88

1038

1673

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8708

35233

1.72

307.65

2.7

7.2

8.5

umol/l

5.98

7140

30800

(3011397) Hemoglobin [Presence] in Urine by Test strip

15634

74280

1.51

307.65

4.0

3.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4429

15172

1.99

307.65

2.4

2.3

5722.2

6123.4

u/l

0.31

1409

6382

(3011288) Drugs identified in Urine by Screen method

6274

7209

6.23

307.65

3.9

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7758

31985

1.67

307.65

1.9

1.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

913

575

10.56

307.65

2.3

2.6

144.5

161.6

nmol/l

2.17

794

491

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5668

20134

1.93

307.65

2.9

3.5

4.5

pmol/l

7.74

4896

18169

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

44812

227992

1.97

307.65

4.2

2.8

49.6

45.1

u/l

17.09

42108

214575

(3028300) Cannabinoids [Presence] in Urine

7150

13218

3.87

307.65

3.0

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

4302

12579

2.34

307.65

1.7

1.6

378.1

285.6

mu/l

15.36

3797

11447

(36660697) Celiac disease serology panel - Serum

6679

26365

1.74

307.65

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1403

1295

7.25

307.65

13.4

783.3

2055.8

nmol/l

0.83

1361

1243

(3001122) Ferritin [Mass/volume] in Serum or Plasma

31438

145724

1.82

307.65

3.2

2.8

101.8

119.9

ug/l

24.55

29107

136236

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3291

9447

2.36

307.65

1.9

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

14157

64444

1.57

307.65

2.8

2.5

6.9

5.6

e6/l

16.01

12398

56133

(3030467) Casts [#/volume] in Urine by Automated count

18344

85444

1.57

307.65

3.4

3.0

0.4

e6/l

1.93

13827

63569

(3006504) Eosinophils/100 leukocytes in Blood

31274

153034

1.67

307.65

6.7

6.0

2.8

2.9

10.05

29098

143154

(3018418) pH of Serum or Plasma

21042

87576

1.86

307.65

4.1

7.4

2.83

3748

17003

(3002030) Lymphocytes/100 leukocytes in Blood

32052

159288

1.64

307.65

6.7

6.0

28.9

28.4

14.17

29803

149106

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10130

43910

1.61

307.65

2.5

2.4

g/l

14.71

9187

40753

(3023368) Bacteria identified in Blood by Culture

17169

80089

1.56

307.65

4.8

4.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11811

48147

1.75

307.65

3.4

3.5

0.8

mmol/l

0.61

10966

45012

(3023103) Potassium [Moles/volume] in Serum or Plasma

58731

341828

2.54

307.65

18.9

14.1

3.9

4.0

mmol/l

82.31

57406

332173

(3021601) Nitrite [Presence] in Urine by Test strip

30264

163318

1.41

307.65

5.4

4.6

0.0

estimate

0.13

6148

31018

(3026782) Osmolality of Urine

13428

59631

1.61

307.65

2.9

2.7

521.1

551.7

mosm/kgh2o

36.62

11431

50740

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

51318

300474

1.61

307.65

6.2

5.2

39.4

39.2

mmol/mol

3.60

47870

280112

(40758558) Short blood count panel - Blood

17870

80040

1.65

307.65

7.4

6.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

14630

69187

1.50

307.65

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

10416

41606

1.77

307.65

1.8

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

10346

44963

1.61

307.65

1.4

1.3

486.0

556.9

titre

3.03

1885

9076

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1477

1367

7.24

307.65

18.3

19.1

1857.7

3279.3

nmol/l

0.50

1414

1305

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7751

28147

1.92

307.65

2.8

2.4

40.1

46.0

u/l

0.39

6555

24209

(3009261) Glucose [Presence] in Urine by Test strip

30527

165000

1.41

307.65

4.1

3.4

0.0

estimate

0.04

5931

30193

(46235355) HIV 1 and 2 tests - Meaningful Use set

16426

71613

1.68

307.65

2.2

1.9

—

(3009508) Creatinine [Moles/volume] in Urine

21257

94384

1.72

307.65

3.5

3.2

7.8

8.0

mmol/l

0.78

17956

80029

(3002582) Erythrocytes [#/volume] in Urine

19715

93744

1.55

307.65

3.5

3.1

55.2

89.1

e6/l

4.33

15107

71236

(3015377) Calcium [Moles/volume] in Serum or Plasma

24597

99808

2.00

307.65

2.9

3.4

2.4

mmol/l

2.53

21647

87644

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3050

4940

4.21

307.65

1.5

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

36797

185952

1.70

307.65

5.5

4.4

6.6

6.7

mmol/l

2.19

34365

172059

(3027008) Opiates [Presence] in Urine

7118

13198

3.86

307.65

2.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

15014

49723

2.28

307.65

1.8

1.7

1168.0

1168.2

nmol/l

0.01

11707

37589

(3007164) IgA [Mass/volume] in Serum or Plasma

15190

64745

1.71

307.65

1.5

1.4

2.3

2.4

g/l

3.82

8545

40994

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12385

56500

1.54

307.65

1.3

30.1

35.3

iu/ml

1.97

3319

18103

(3021960) Folate [Moles/volume] in Serum or Plasma

17450

64892

2.05

307.65

1.6

1.5

19.9

20.5

nmol/l

4.74

15430

55736

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

33679

149198

2.02

307.65

6.9

6.5

1.2

mmol/l

0.05

28735

125588

(3024561) Albumin [Mass/volume] in Serum or Plasma

29231

131470

1.85

307.65

4.8

36.1

35.8

g/l

19.40

27056

122171

(3001604) Monocytes [#/volume] in Blood

33911

162110

1.79

307.65

6.6

5.8

0.6

e9/l

5.32

29305

141409

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14885

62144

1.75

307.65

1.7

1.6

30473502.5

38186526.4

pmol/l

0.82

12493

51888

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

16430

37023

3.57

307.65

2.2

1.6

1.5

1.4

127.01

14533

33012

(3027944) Amphetamines [Presence] in Urine

6880

13121

3.74

307.65

2.8

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2181

5530

2.65

307.65

3.0

2.7

33.4

34.3

umol/l

0.66

1885

4683

(3007853) Bacteria identified in Skin by Aerobe culture

8871

37105

1.66

307.65

1.9

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8785

27278

2.29

307.65

2.0

2.3

371.4

376.6

nmol/l

1.42

7977

25281

(3023511) Choriogonadotropin [Units/volume] in Urine

2791

6993

2.69

307.65

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

59458

362965

2.05

307.65

12.4

9.4

27.9

26.6

u/l

20.55

57822

350864

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26191

104044

2.10

307.65

3.6

3.1

32.2

33.3

u/l

0.82

24615

98942

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

29523

129599

1.92

307.65

2.5

2.2

3111.8

76.7

nmol/l

0.50

26988

117680

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

980

828

7.88

307.65

2.7

1.4

168.1

101.0

umol/l

5.08

517

406

(3019198) Lymphocytes [#/volume] in Blood

34669

167907

1.78

307.65

6.7

5.8

2.0

1.9

e9/l

9.95

30499

149090

(3013707) Erythrocyte sedimentation rate by Westergren method

45933

242753

1.86

307.65

4.4

3.9

11.4

11.3

mm/h

0.64

42643

225773

(3035350) Ketones [Presence] in Urine by Test strip

30385

162732

1.43

307.65

4.1

3.4

0.0

estimate

3.11

5931

30258

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

12961

46492

2.04

307.65

2.5

2.0

—

(42870588) Differential panel, method unspecified - Blood

23775

108918

1.69

307.65

6.1

6.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10994

47281

1.64

307.65

2.0

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

53289

315732

1.64

307.65

14.7

11.6

88.7

84.1

ml/min/173m2

307.65

43865

258730

(3018095) Leukocytes [#/volume] in Urine

23167

111335

1.57

307.65

4.1

3.5

75.0

92.0

e6/l

2.65

16214

77283

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

6156

20936

2.03

307.65

2.1

1.8

—

(3016879) Cocaine [Presence] in Urine

6912

11869

4.17

307.65

3.0

1.6

—

(40761511) CBC panel - Blood by Automated count

58227

358490

1.73

307.65

16.0

11.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

29275

119889

2.11

307.65

2.1

1.9

96.8

96.6

pmol/l

0.34

15909

62606

(3019069) Monocytes/100 leukocytes in Blood

31431

153911

1.67

307.65

6.9

6.2

8.3

8.5

45.63

29387

144760

(3028707) Methadone [Presence] in Urine by Screen method

5300

3079

12.23

307.65

3.2

2.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

3339

2490

9.24

307.65

6.1

4.0

374.3

363.8

umol/l

2.19

2955

2128

(3000764) Benzodiazepines [Presence] in Urine

7137

13043

3.92

307.65

3.0

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

17696

74609

1.77

307.65

1.4

1.3

1.4

1.7

u/ml

2.83

4462

20846

(3019150) Specific gravity of Urine by Refractometry

15870

68995

1.68

307.65

4.3

3.7

1.0

kg/l

0.34

1936

10849

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

12002

41838

2.09

307.65

2.3

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

11032

47763

1.62

307.65

2.5

13.3

13.9

umol/l

0.64

10136

44396

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

18460

75160

1.86

307.65

2.4

2.2

2.9

mg/l

1.44

15765

64466

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

31104

134366

2.01

307.65

6.2

5.9

1.2

mmol/l

2.83

28497

121782

(3048689) Calprotectin [Mass/mass] in Stool

10347

41575

1.76

307.65

2.2

2.5

117.1

136.1

ug/g

6.34

7905

33080

(3013115) Eosinophils [#/volume] in Blood

34914

168440

1.79

307.65

7.1

6.0

0.2

e9/l

0.31

30670

149000

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11395

52225

1.53

307.25

2.8

2.7

1.2

1.1

e6/l

0.11

6174

29458

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

11576

53269

1.52

306.21

1.3

9.9

11.5

u/ml

1.29

4076

21506

(3012544) pH of Venous blood

6805

27564

1.70

305.16

4.2

3.9

7.4

0.13

135

(3002385) Erythrocyte distribution width [Ratio]

48449

287625

1.44

300.64

20.9

14.9

13.6

3.92

47576

281556

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12686

59718

1.49

300.31

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1653

3887

2.84

294.49

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

8420

36549

1.59

286.29

7.5

7.2

104.2

104.5

mmol/l

8.18

8236

35784

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10647

48756

1.52

285.63

3.0

2.8

4.0

2.9

e6/l

8.55

5454

26157

(3024354) Oxygen [Partial pressure] in Venous blood

5512

21700

1.73

272.05

3.6

3.2

4.8

4.6

kpa

7.49

5260

21030

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5476

21578

1.73

269.26

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

9463

42744

1.53

268.63

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3863

13732

1.90

265.49

4.4

4.3

24.2

24.1

mmol/l

0.76

3428

12397

(3000991) Gas panel - Venous blood

6005

24410

1.68

263.33

8.5

8.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4723

17938

1.79

263.26

3.6

3.5

5.2

5.1

kpa

8.45

4423

16542

(3009343) pH of Capillary blood

4667

17700

1.79

261.30

3.6

3.4

7.4

0.56

609

2391

(3023323) Follitropin [Units/volume] in Serum or Plasma

4540

17115

1.80

259.22

1.4

1.3

23.9

27.3

iu/l

9.38

3736

14928

(3029937) Albumin [Presence] in Urine by Test strip

17095

87047

1.40

258.62

4.6

3.8

0.0

estimate

3.24

5956

29893

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2464

7490

2.21

257.57

1.3

498.3

546.0

mg/l

1.36

2339

7149

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4530

17100

1.80

257.45

3.5

3.4

1.6

1.7

mmol/l

0.70

3396

12449

(3027801) Oxygen [Partial pressure] in Arterial blood

7555

32770

1.58

255.23

7.7

7.4

12.0

12.8

kpa

30.15

7228

31235

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7556

32789

1.58

254.74

7.7

7.4

5.2

5.1

kpa

11.11

7233

31270

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8296

36829

1.55

253.21

7.6

6.4

—

(3003396) Base excess in Arterial blood by calculation

7545

32787

1.58

252.70

7.7

7.4

1.1

1.0

mmol/l

2.25

5975

25772

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5773

23516

1.67

250.46

1.2

114.3

148.8

iu/ml

7.91

1941

9154

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2227

6567

2.27

250.02

1.4

29.1

31.9

e6/l

0.13

1703

5087

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2228

6573

2.27

249.86

1.4

2653.9

1864.0

e6/l

0.19

1800

5347

(3042936) Bacteria identified in Isolate by Culture

9521

43739

1.50

247.62

2.2

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12043

58120

1.44

243.72

4.0

3.5

263.3

539.5

ng/l

11.95

8029

42995

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2203

6574

2.24

240.41

1.2

1.3

3.8

3.7

mmol/l

2.35

2052

6184

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1695

4522

2.50

236.67

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2596

8335

2.09

236.33

1.4

285.0

274.7

ug/g

1.19

1425

4832

(3000494) Fungus identified in Specimen by Culture

8157

36667

1.53

233.63

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

40819

239674

1.33

226.84

3.6

3.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3569

13004

1.85

226.31

1.1

8.5

8.9

u/ml

0.02

200

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16139

82901

1.37

225.06

1.7

1.6

1.4

mmol/l

100.93

13813

70154

(3009214) Lutropin [Units/volume] in Serum or Plasma

3017

10504

1.93

219.39

1.4

9.3

9.7

u/l

0.60

2385

8728

(3016502) Oxygen saturation in Arterial blood

6697

29309

1.56

214.95

8.1

7.8

95.4

95.9

6.68

6487

28170

(40760892) CBC W Ordered Manual Differential panel - Blood

14808

75717

1.37

209.61

5.0

4.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1756

5104

2.29

203.33

1.4

1.3

22.3

26.2

u/l

4.96

1375

4297

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2831

9908

1.92

202.38

2.3

567.5

506.7

ug/l

0.28

2619

9253

(3013512) EKG study

16579

86690

1.35

201.70

3.9

3.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

8708

40808

1.46

200.94

1.8

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6192

27025

1.56

200.21

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

9692

46504

1.43

197.06

2.1

29.5

29.8

3.98

9387

45130

(3019225) pH of Specimen

6507

28861

1.53

195.46

4.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4425

17932

1.67

193.39

1.1

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

5916

25752

1.56

193.10

7.9

7.7

8.5

9.6

mmol/l

28.52

5628

24547

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4308

17349

1.68

192.75

1.6

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1994

6272

2.12

190.78

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4115

16458

1.69

188.77

1.8

1.6

—

(4010399)

5219

22174

1.59

188.71

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

4069

41967

0.61

185.97

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

5550

24028

1.57

185.04

2.4

2.7

10.3

10.6

g/l

6.95

5000

22065

(3014765) Yersinia sp identified in Stool by Organism specific culture

2614

9176

1.91

184.89

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2595

9088

1.91

184.82

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

19016

102468

1.31

183.85

2.5

2.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

2615

9206

1.90

183.34

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6115

27248

1.52

178.80

8.6

8.2

123.0

121.8

g/l

4.72

5928

26238

(3022313) Gas panel - Capillary blood

3322

12699

1.76

178.79

3.7

3.6

—

(3012516) Albumin [Mass/volume] in Urine

16490

87562

1.32

175.29

3.4

3.3

403.0

423.6

mg/l

0.21

10538

55386

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

54497

338224

1.39

172.71

5.0

4.5

2.8

mmol/l

0.06

50560

314784

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5049

21755

1.57

171.17

3.9

88.2

89.7

ng/l

0.47

4362

18915

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4330

18068

1.62

167.75

7.0

7.2

24.9

24.8

mmol/l

0.92

4279

17914

(3020682) Albumin/Creatinine [Ratio] in Urine

17169

92167

1.31

166.85

4.2

4.0

10.3

9.1

mg/mmol

1.79

10862

58549

(3007461) Platelets [#/volume] in Blood

60773

385834

1.67

166.75

26.3

18.1

261.3

252.9

e9/l

180.42

59561

375990

(3019060) Gas panel - Arterial blood

4417

18563

1.60

166.14

5.2

4.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

814

1771

3.04

165.50

1.7

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2987

11376

1.76

162.44

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

15215

80583

1.31

162.23

2.9

1065.8

1323.9

ng/l

9.52

12425

68424

(3035941) MCH [Entitic mass]

60781

386189

1.66

160.67

26.1

18.0

30.2

3.97

60095

381088

(3024731) MCV [Entitic volume]

60785

386235

1.65

160.38

26.1

18.0

90.6

0.59

60094

381118

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3246

12711

1.71

160.05

1.3

1.2

0.5

0.9

u/ml

2.16

279

1086

(3026361) Erythrocytes [#/volume] in Blood

60788

386278

1.65

159.98

26.2

18.1

4.5

e12/l

31.45

59442

375413

(3010813) Leukocytes [#/volume] in Blood

60793

386370

1.65

158.90

26.3

18.1

6.9

6.7

e9/l

119.04

59459

375482

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2930

11180

1.76

158.22

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

129

53.05

157.67

1.4

1.1

502.0

432.9

nmol/l

0.27

129

(3000963) Hemoglobin [Mass/volume] in Blood

60792

386429

1.65

157.52

26.4

18.2

135.2

136.2

g/l

60.50

60108

381375

(3025941) Bacteria identified in Stool by Culture

4522

19364

1.57

156.83

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

53657

333260

1.35

155.89

4.6

4.1

4.7

mmol/l

11.01

50039

312037

(40761535) Cells panel - Urine sediment

5474

24537

1.51

154.33

3.9

3.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6858

32184

1.45

153.56

2.6

1.8

3.34

5980

28646

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2897

11161

1.74

151.15

3.9

3.7

24.8

mmol/l

0.29

2733

10312

(3013139) Helicobacter pylori Ag [Presence] in Stool

4886

21544

1.53

148.45

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22705

127785

1.26

146.23

4.4

3.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

53222

330905

1.33

144.84

4.5

4.0

1.4

1.5

mmol/l

233.37

49365

308685

(3052851) Hemolysis interference index of Serum or Plasma

2428

8993

1.80

144.63

3.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

51577

319312

1.31

144.09

4.1

3.7

1.4

1.3

mmol/l

294.94

47483

296568

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14526

77583

1.30

141.97

2.5

2.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4983

22298

1.51

140.97

2.4

2.3

23.6

23.3

au/ml

0.05

220

1468

(3020891) Body temperature

2850

11170

1.71

139.64

5.5

4.8

—

(3008295) Osmolality of Serum or Plasma

984

2604

2.50

139.41

1.6

1.5

281.9

279.4

mosm/kgh2o

2.27

726

2086

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4178

18039

1.56

139.13

9.5

9.3

1.6

1.3

26.75

4161

17917

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4165

18024

1.55

137.24

9.6

9.4

0.7

0.01

4149

17918

(3014007) Fractional oxyhemoglobin in Arterial blood

4183

18122

1.55

137.15

9.6

9.4

93.4

94.1

9.58

4171

18052

(3003181) Sodium [Moles/volume] in Urine

1441

4542

2.11

136.79

1.5

1.4

58.9

64.6

mmol/l

5.02

1093

3616

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4601

20369

1.52

136.71

1.3

48.9

49.0

au/ml

0.00

131

870

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3245

13238

1.64

136.66

3.4

2.9

1.6

1.2

35.68

3228

13170

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5349

24442

1.48

136.39

4.0

3.8

1.2

mmol/l

1.62

4614

21426

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5398

24764

1.47

134.83

2.6

2.1

12.2

12.6

nmol/l

3.69

4688

22349

(3028026) IgM [Mass/volume] in Serum or Plasma

4265

18649

1.54

134.04

1.8

1.9

1.3

g/l

0.18

3869

17070

(3023410) Appearance of Cerebral spinal fluid

1061

2975

2.36

132.93

1.6

1.5

—

(3007463) Buprenorphine [Presence] in Urine

142

17.30

130.62

7.0

10.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

624

1337

3.09

130.17

1.9

1.5

2136929.8

1549838.2

iu/ml

0.51

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3572

15103

1.59

129.88

9.5

9.7

24.3

mmol/l

0.01

3280

14172

(3004716) Salmonella sp identified in Stool by Organism specific culture

4155

18185

1.54

129.88

1.3

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3161

12978

1.63

129.64

3.4

2.8

0.7

0.07

3030

12465

(3007566) Smooth muscle Ab [Titer] in Serum

2347

8897

1.76

129.14

1.2

1.3

105.2

122.0

titre

0.45

212

827

(3004119) Hemoglobin [Mass/volume] in Venous blood

3987

17334

1.54

128.37

3.7

3.3

130.6

129.6

g/l

1.96

3882

16943

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

27058

156779

1.23

128.08

4.2

3.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

231

212

7.18

127.97

6.9

7.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1759

6115

1.91

127.45

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1758

6113

1.91

127.29

1.4

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1928

6914

1.86

127.12

2.1

1.8

189.0

198.5

pmol/l

3.08

1802

6615

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5242

24186

1.46

126.76

2.5

2.2

6.6

7.4

ug/l

1.50

4432

21176

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4083

17894

1.53

126.73

8.0

6.9

24.8

24.6

mmol/l

3.23

3852

16627

(3018405) Lactate [Moles/volume] in Arterial blood

2500

9749

1.71

124.48

4.6

4.1

1.4

mmol/l

0.44

2473

9573

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3837

36769

0.67

120.42

1.6

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3750

16377

1.53

117.98

1.1

168.5

194.9

titre

0.22

466

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9068

75143

0.76

116.99

3.9

4.0

21.4

21.9

2.35

3617

34275

(3034770) Mitochondria Ab [Titer] in Serum

2274

8786

1.73

116.93

1.2

723.9

988.6

titre

0.95

257

(3016650) Hepatitis A virus Ab [Presence] in Serum

1563

5387

1.93

116.09

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

5638

26828

1.42

114.85

4.2

4.1

0.8

1.0

2.01

1505

7316

(1616796) Gas panel - Central venous blood

1811

6578

1.83

114.59

3.8

3.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2545

10200

1.66

114.34

2.0

1.7

39.1

40.9

nmol/l

2.57

2476

9984

(3010421) pH of Blood

2061

7794

1.76

114.16

4.4

3.7

7.4

8.29

1759

6623

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

3040

12747

1.59

114.08

1.6

3.6

3.4

mg/l

0.60

2428

8491

(3005322) IgE [Units/volume] in Serum or Plasma

4693

21656

1.46

112.76

1.3

252.4

248.9

u/ml

0.05

4282

20121

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

525

1112

3.12

111.66

1.4

73.4

72.5

0.61

492

1067

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6315

54723

0.73

110.26

2.7

2.8

0.6

0.8

ug/l

12.07

4264

34050

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

516

1090

3.13

110.23

1.4

576.5

711.3

mu/l

0.55

483

1045

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

193

173

7.35

108.99

1.1

1.3

50.7

45.6

mg/l

0.56

(1002224) Polysomnography panel

3296

14258

1.55

107.97

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1912

7193

1.77

107.74

3.1

2.9

24.7

24.6

mmol/l

0.43

1707

6315

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2004

7647

1.74

107.54

1.2

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

886

2523

2.32

107.27

1.7

2.2

19.5

19.7

nmol/l

0.25

823

2405

(3002179) Metamyelocytes/100 leukocytes in Blood

5153

24433

1.42

106.66

3.9

4.0

0.6

0.7

1.48

1076

5324

(3021440) Promyelocytes/100 leukocytes in Blood

5344

25588

1.41

104.52

4.3

4.2

0.1

0.81

1371

6804

(3027315) Oxygen [Partial pressure] in Blood

1818

6809

1.78

103.96

4.5

3.7

8.8

8.7

kpa

1.61

1767

6659

(3012501) Base excess in Blood by calculation

1809

6766

1.78

103.93

4.5

3.7

2.4

2.5

mmol/l

0.36

1258

4511

(3013290) Carbon dioxide [Partial pressure] in Blood

1809

6768

1.78

103.82

4.5

3.7

5.1

5.0

kpa

5.99

1758

6619

(1761868) Lipid panel - Serum or Plasma

17082

129974

0.81

103.67

2.8

2.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1223

4025

2.01

103.48

2.0

1.8

4167.6

3758.6

titre

0.11

168

(3016018) Differential panel - Cerebral spinal fluid

1055

3292

2.12

102.70

1.5

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

2137

8414

1.69

102.46

4.9

4.4

3.8

3.9

mmol/l

5.29

2016

7917

(3025159) Blasts/100 leukocytes in Blood

5075

24198

1.41

101.53

4.4

4.2

0.0

0.2

4.49

1169

5774

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

246

317

5.11

99.99

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1273

4305

1.96

99.83

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2717

11446

1.58

99.70

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1496

5348

1.86

99.44

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

7418

37744

1.33

98.50

19.3

22.9

1.2

1.3

inr

5.72

1001

5562

(3028626) Oxygen [Partial pressure] in Capillary blood

1758

6652

1.76

97.05

2.9

3.0

8.5

8.4

kpa

2.34

1645

6178

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2041

8104

1.68

94.76

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2429

10094

1.60

94.27

1.8

1.7

1.2

g/l

5.16

2302

9629

(3024928) Oxygen saturation in Venous blood

1612

6006

1.78

93.75

3.4

3.3

—

(3036180) Methadone [Presence] in Urine

32.49

93.69

2.9

3.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2365

9803

1.61

92.73

1.8

1.7

0.2

g/l

0.53

2235

9316

(3022145) Colonoscopy Study observation

7104

36234

1.32

92.26

1.3

1.4

—

(3008898) HLA-B27 [Presence]

2802

12102

1.54

92.10

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

912

2811

2.15

91.59

1.6

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

15041

84126

1.23

91.27

2.5

2723.0

4136.5

umol/l

5.68

12846

74038

(3035637) Corticotropin [Mass/volume] in Plasma

1132

3791

1.98

91.26

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2748

11842

1.55

91.23

1.3

—

(3017509) Phencyclidine [Presence] in Urine

236

323

4.81

89.98

2.3

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

4912

23819

1.38

88.41

2.4

2.7

72.8

69.6

e9/l

6.64

3619

17975

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12111

94174

0.81

86.80

4.2

4.6

2.2

2.9

ug/l

3.43

10690

85366

(3020630) Protein [Mass/volume] in Serum or Plasma

4819

23365

1.38

86.73

2.1

2.6

66.7

66.6

g/l

0.51

4328

21349

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

10794

58510

1.25

86.56

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7552

39192

1.30

86.02

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1477

5505

1.78

85.77

1.5

1.4

0.4

nmol/l

0.21

1152

4357

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2809

12330

1.52

85.63

1.6

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6132

30960

1.33

84.95

4.1

3.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

51296

322228

1.23

83.85

18.9

13.1

39.9

40.2

11.84

36752

245106

(3016244) Insulin [Units/volume] in Serum or Plasma

716

2083

2.27

82.64

3.2

33.0

25.4

mu/l

3.58

667

1960

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1002

3345

1.98

81.52

1.3

38.2

26.0

nmol/l

0.72

(3027273) Bicarbonate [Moles/volume] in Venous blood

3044

13753

1.48

80.60

3.9

3.4

25.3

mmol/l

0.58

2931

13343

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

836

2629

2.10

79.84

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

19.97

79.59

1.7

1.1

263.5

204.2

nmol/l

0.44

(40767503) Oxygen content in Capillary blood by calculation

1617

6330

1.70

79.04

2.7

2.4

16.8

16.6

1.30

829

3247

(3021901) Oxygen saturation in Capillary blood

1394

5234

1.77

78.96

2.7

2.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2831

12676

1.49

78.34

4.3

3.8

51.3

48.2

8.23

2789

12548

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2598

24814

0.67

78.16

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2328

10077

1.54

75.53

1.9

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

1261

4699

1.78

73.27

2.2

1.8

1.7

mmol/l

0.15

1232

4590

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

889

2962

1.98

72.76

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2115

9042

1.55

72.51

1.3

30.6

36.7

u/ml

0.47

104

562

(43055514) Macroprolactin [Presence] in Serum or Plasma

374

840

2.94

72.33

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

812

2641

2.03

71.01

1.1

1.2

36.7

45.0

mg/l

4.37

679

2213

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6606

34502

1.29

70.57

3.6

4.3

230.6

243.3

u/l

10.92

6182

32750

(3026389) Candida sp identified in Specimen by Organism specific culture

1251

4704

1.76

70.51

1.4

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1299

4939

1.74

70.46

2.3

2.1

6.6

7.1

titre

0.07

134

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

21.22

70.34

1.7

1.2

273.4

341.5

nmol/l

0.21

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

574

1635

2.32

69.61

1.0

35.7

43.2

ng/l

3.11

398

1166

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

572

1633

2.31

69.02

1.0

804.5

734.8

ng/l

2.70

400

1131

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

569

1623

2.31

68.80

1.0

251.2

354.4

ng/l

4.48

406

1175

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

782

2553

2.02

67.72

1.1

241.2

273.4

mg/l

2.52

677

2253

(3004588) Protein electrophoresis panel - Serum or Plasma

3900

18993

1.37

67.65

2.0

2.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1653

6778

1.62

67.56

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1642

6734

1.62

67.07

1.2

40.6

43.5

u/ml

0.27

143

682

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2922

13605

1.43

65.82

1.9

2.0

39.8

39.5

u/l

0.40

2627

12189

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7088

37690

1.26

65.08

4.5

4.2

30.6

32.4

34.86

5213

26246

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

756

2483

2.01

64.43

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1045

3829

1.81

64.23

2.1

1.7

89.9

90.1

0.43

1026

3773

(4027681)

651

2023

2.12

64.18

1.2

1.3

—

(3036489) Thrombin time

2679

12333

1.45

64.12

2.1

21.1

21.4

1.53

2308

10654

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2885

13505

1.42

63.04

1.4

1.6

12.3

14.5

u/ml

0.32

409

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

601

1829

2.17

62.44

1.3

1.2

5.1

5.2

umol/l

0.27

545

1704

(3021367) Citalopram [Moles/volume] in Serum or Plasma

20.03

62.18

1.5

1.2

132.6

147.8

nmol/l

0.21

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

729

2394

2.01

62.17

1.2

1.3

2.0

2.1

mmol/l

0.70

669

2224

(3039443) Prostate specific Ag panel - Serum or Plasma

455

6507

0.46

60.87

1.4

1.6

—

(40768804) Tissue Pathology biopsy report

22602

134622

1.16

60.57

2.1

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3322

16098

1.37

59.21

10.3

9.7

—

(40761536) Microorganisms panel - Urine sediment

5466

28474

1.28

58.93

4.5

3.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2324

10632

1.45

57.41

1.6

311.7

285.1

titre

0.14

445

(3012920) Ethanol [Mass/volume] in Serum or Plasma

16.18

57.34

1.5

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1123

4356

1.71

56.78

1.3

0.1

0.3

nmol/l

4.04

250

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

9.86

56.38

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

710

2395

1.96

56.22

1.1

709.5

289.9

mg/l

0.50

636

2157

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

552

1704

2.14

55.42

1.1

2.5

5.7

nmol/l

1.28

340

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1571

6676

1.56

55.24

1.3

267.5

259.7

u/ml

0.47

1032

4273

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1854

8177

1.50

55.00

1.9

8.7

19.2

iu/l

0.63

652

3084

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1894

8397

1.50

54.79

1.3

7.1

9.4

u/ml

0.75

245

1337

(3037121) Protein [Mass/volume] in Urine

2276

10502

1.44

53.69

3.1

3.2

0.3

g/l

1.67

974

4746

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2390

11133

1.43

53.55

2.2

2.0

2.1

2.3

ug/l

0.44

2115

9820

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2760

13190

1.39

53.41

1.7

1.8

1.5

g/l

0.09

2385

11273

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1645

7118

1.53

53.35

1.2

1.3

—

(3016038) Potassium [Moles/volume] in Urine

554

1745

2.09

52.87

1.3

31.2

34.8

mmol/l

2.94

463

1520

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1112

4390

1.68

52.71

1.3

1.0

1.4

nmol/l

0.32

1069

4238

(3017732) Neutrophils [#/volume] in Blood

4479

23071

1.30

52.40

3.1

2.6

4.1

e9/l

0.58

3404

18261

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

391

1068

2.41

52.15

1.3

1.4

13.3

15.3

pmol/l

8.47

316

912

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1613

6989

1.53

51.99

2.2

132.3

131.0

g/l

1.26

1188

5133

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2571

12206

1.40

51.69

1.3

223.1

224.4

miu/ml

0.05

982

5938

(3024980) IgG subclass 4 [Mass/volume] in Serum

1279

5269

1.61

51.31

1.5

1.6

0.7

0.8

g/l

2.32

970

3959

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1850

8292

1.48

50.71

1.3

5.9

7.4

u/ml

0.43

154

891

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1455

6197

1.55

50.67

2.7

2.0

0.9

0.8

nmol/l

3.11

1208

5225

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1012

3949

1.69

50.11

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

429

1247

2.27

49.85

2.7

2.3

54.7

53.7

umol/l

0.26

354

1035

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1982

9052

1.45

49.35

2.1

2.4

0.7

0.8

g/l

1.10

1695

7798

(3041096) Erythrocytes [Presence] in Urine by Automated

15651

91761

1.16

49.23

3.7

3.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2135

9902

1.43

48.96

1.1

4.0

5.4

u/ml

0.89

218

1387

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

638

2186

1.93

48.37

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

641

2201

1.92

48.30

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1211

4998

1.60

48.24

3.5

3.1

64.3

65.0

0.45

1203

4978

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

734

2637

1.84

48.18

1.4

1.3

1.5

1.4

nmol/l

2.09

675

2372

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1669

7404

1.49

48.13

2.0

2.3

0.0

g/l

0.59

1496

6757

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1785

8031

1.47

48.01

2.0

2.3

0.0

g/l

1.05

1611

7361

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

516

1644

2.07

47.86

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

368

1018

2.38

47.81

2.9

29.3

28.4

umol/l

0.52

261

788

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

539

1748

2.03

47.69

1.4

1.5

6.0

5.9

u/l

0.06

434

1488

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

506

1605

2.08

47.48

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1600

7068

1.50

47.10

1.4

16.1

20.4

u/ml

0.77

137

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2068

9611

1.43

46.88

2.4

2.6

183.5

184.9

0.27

1952

9108

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2629

12743

1.37

46.59

2.2

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1818

8269

1.46

46.24

2.0

2.2

38.3

37.8

g/l

2.51

1559

7113

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3152

15731

1.33

46.15

2.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

430

1294

2.19

46.08

1.8

2.0

umol/l

0.24

397

1218

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1537

6769

1.50

45.91

1.2

3.1

5.7

u/ml

1.21

537

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1638

7310

1.48

45.88

2.0

2.3

0.0

g/l

0.00

1490

6739

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1604

7129

1.49

45.84

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2144

10086

1.41

45.40

2.0

2.3

3.0

3.1

g/l

1.91

1664

7839

(3011985) Renin [Units/volume] in Plasma

1052

4263

1.63

45.14

1.6

62.4

63.8

mu/l

0.09

929

3838

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1874

8616

1.44

45.04

1.4

1.5

17.3

13.0

iu/ml

0.42

204

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

457

1434

2.10

44.15

1.6

15.2

5.2

nmol/l

0.40

370

1207

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1000

4029

1.64

43.91

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

406

1218

2.20

43.87

1.8

28.4

29.0

umol/l

0.50

393

1173

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2245

10715

1.39

43.69

2.0

2.3

7.3

7.4

g/l

1.70

1703

8003

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2242

10702

1.39

43.60

2.0

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2404

11617

1.37

43.39

2.0

1.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

479

1541

2.05

43.36

1.2

1.3

60.0

64.6

0.39

191

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2110

9986

1.40

43.15

2.0

2.3

9.9

10.3

g/l

3.69

1751

8353

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1506

6697

1.49

42.94

1.2

14.3

14.7

u/ml

0.01

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2206

10529

1.39

42.92

2.3

93.9

92.4

2.19

2049

9782

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1579

7094

1.47

42.78

1.7

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2233

10687

1.39

42.74

2.0

2.3

3.8

g/l

0.29

1643

7616

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1481

6574

1.49

42.60

1.5

110.7

110.8

u/ml

0.00

339

1478

(3025130) Human papilloma virus identified in Specimen

1162

4898

1.57

42.39

1.7

—

(3000492) Spirometry study

6121

33471

1.22

42.32

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

964

3888

1.64

42.18

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1923

8993

1.42

42.10

1.9

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

973

3936

1.63

42.07

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

964

3892

1.64

42.01

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

643

2316

1.83

41.94

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

964

3897

1.63

41.80

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

473

1539

2.03

41.57

1.6

1.5

19.4

26.7

umol/l

6.98

444

1468

(3024522) Salmonella sp identified in Specimen by Organism specific culture

971

3942

1.63

41.40

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

954

3856

1.63

41.39

7.0

6.1

11.2

11.3

mg/l

0.44

871

3544

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2093

9964

1.39

41.35

2.8

2.6

3.6

g/l

0.19

1991

9501

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1283

5575

1.52

40.86

1.7

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

357

1050

2.24

40.49

1.9

2.4

1.0

1.1

ug/l

0.52

329

990

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

529

1809

1.93

40.44

1.1

1.0

1.1

u/l

0.84

211

838

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1196

5131

1.54

40.38

1.1

791.9

2564.8

iu/ml

0.42

278

1178

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

965

3942

1.62

40.15

1.4

337.8

295.8

pmol/l

1.68

765

3066

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1043

4349

1.58

39.87

1.1

1.5

g/l

0.00

940

3945

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1890

8899

1.41

39.81

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

599

2149

1.84

39.60

1.2

—

(3003338) MCHC [Mass/volume]

47330

300200

1.14

39.01

23.0

15.5

332.5

332.9

g/l

13.24

46977

297876

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

470

1574

1.97

38.19

1.9

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1836

8688

1.40

37.58

1.9

2.1

11.1

10.7

mg/l

0.81

1711

8128

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

860

3477

1.63

37.33

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1191

5198

1.51

37.19

1.9

2.2

6.5

umol/l

0.04

871

3796

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1505

6896

1.44

36.86

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

445

1482

1.98

36.76

2.1

17.2

24.9

umol/l

1.00

139

(3047181) Lactate [Moles/volume] in Blood

1979

9527

1.38

36.55

6.5

5.5

1.3

mmol/l

1.68

1754

8415

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

585

2137

1.80

36.55

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

344

1042

2.17

36.42

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1282

5710

1.48

36.31

3.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

478

1645

1.91

35.94

1.3

1.2

273.8

329.4

u/l

0.63

446

1539

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

585

2149

1.79

35.89

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

315

930

2.23

35.49

1.2

22.5

19.8

0.20

170

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4704

25486

1.23

35.26

2.6

71.0

67.5

ml/min/173m2

6.19

1911

9792

(3040151) Glucose [Moles/volume] in Capillary blood

827

3365

1.62

35.03

9.3

7.7

7.4

7.3

mmol/l

0.27

672

2753

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1093

4769

1.51

34.21

1.3

—

(4062490)

822

3364

1.61

34.03

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

588

2204

1.76

33.76

1.1

—

(3045414) Leukocytes [Presence] in Urine

2821

14473

1.29

33.68

1.9

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

265

743

2.35

33.63

1.4

1.3

17.0

16.7

umol/l

0.43

233

664

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

876

3666

1.58

33.06

2.2

2.0

21.5

27.0

mg/l

2.53

259

966

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.04

33.04

1.2

1.1

—

mmol/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

194

471

2.71

32.99

1.5

1.3

64.9

275.1

ng/l

0.66

110

317

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

656

2561

1.69

32.62

1.1

73.1

61.7

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

373

1218

2.02

32.61

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1142

5084

1.48

32.47

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

814

3363

1.60

32.44

1.4

0.4

g/l

2.21

577

2325

(3028192) IgG subclass 2 [Mass/volume] in Serum

814

3365

1.60

32.36

1.4

2.9

3.0

g/l

0.41

574

2319

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1168

5228

1.48

32.33

1.3

1.2

3.7

3.9

u/ml

0.19

519

2355

(3027135) IgG subclass 1 [Mass/volume] in Serum

814

3368

1.59

32.25

1.4

6.5

6.8

g/l

1.53

572

2323

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1161

5205

1.47

31.88

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

952

4106

1.53

31.48

1.2

49.5

52.1

u/ml

0.10

275

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4391

23910

1.22

31.22

2.8

152.2

196.1

ng/l

9.04

3909

21695

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1436

6726

1.41

31.21

5.6

5.8

4785.3

1118.7

iu/ml

0.47

166

1013

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2129

10625

1.33

31.09

1.7

1.6

7.2

5.8

iu/ml

0.07

429

2223

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

210

548

2.52

31.07

1.3

1.7

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

14.78

31.01

2.9

3.7

333.9

432.3

nmol/l

0.59

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

357

1171

2.01

30.86

2.6

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

256

739

2.28

30.49

1.4

1.2

133.5

129.8

nmol/l

0.10

172

564

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2388

12146

1.30

30.42

5.7

4.8

1.9

1.7

15.58

2240

11377

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

595

2307

1.70

30.38

1.3

1.4

11.7

12.0

umol/l

0.55

547

2209

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

599

2336

1.69

29.95

2.7

2.5

809.9

719.6

e6/l

0.84

231

956

(44813793)

622

2451

1.67

29.93

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

921

3995

1.52

29.70

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1183

5410

1.44

29.35

1.2

1.3

2.7

3.8

u/ml

2.01

390

1881

(3023420) DNA double strand Ab [Units/volume] in Serum

844

3604

1.55

29.24

1.6

34.7

33.9

iu/ml

0.04

168

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1148

5228

1.45

29.12

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1945

9672

1.33

29.12

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

776

3261

1.57

28.85

1.2

57.7

64.0

u/l

1.80

537

2208

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3073

16245

1.25

28.70

2.9

2.6

0.3

e6/l

0.43

2993

15757

(3027923) C peptide [Moles/volume] in Serum or Plasma

449

1632

1.81

28.65

1.6

1.3

1.2

nmol/l

1.15

335

1310

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

492

1841

1.76

28.51

1.3

—

(40768443) Skin Pathology biopsy report

2679

13963

1.27

28.20

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

754

3167

1.57

28.10

1.6

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1842

9145

1.33

27.90

1.2

—

(40768800) Prostate Pathology biopsy report

515

5589

0.60

27.78

1.2

—

(3045716) Anion gap in Serum or Plasma

370

1278

1.91

27.68

2.3

2.5

9.2

9.1

mmol/l

0.25

283

927

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

298

954

2.06

27.58

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

365

1257

1.91

27.55

2.3

1.9

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

518

1988

1.72

27.51

2.2

2.1

98.8

97.6

0.29

484

1848

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1102

5036

1.44

27.48

1.1

120.8

117.9

2.09

1000

4553

(40759836) Histone Ab [Presence] in Serum by Immunoblot

622

2510

1.63

27.36

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1753

8666

1.34

27.34

3.6

3.5

1.5

mg/l

0.13

1620

8012

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

623

2516

1.63

27.32

1.2

—

(4306422)

1135

5230

1.43

27.07

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

621

2515

1.63

26.94

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

624

2538

1.62

26.62

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

208

583

2.35

26.55

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

624

2540

1.62

26.54

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

624

2544

1.62

26.37

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1282

6066

1.40

26.34

1.2

77.4

140.2

titre

1.45

127

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

983

4434

1.46

26.26

1.5

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2311

11947

1.28

25.98

5.9

4.9

0.9

0.08

2173

11190

(3019420) Tryptase [Mass/volume] in Serum or Plasma

471

1791

1.73

25.88

1.4

1.5

6.6

8.3

ug/l

2.15

426

1618

(3013247) Albumin in CSF/Albumin in Serum or Plasma

235

705

2.19

25.67

1.1

6.1

7.4

mg/g

1.78

223

670

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

243

743

2.15

25.35

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

860

3813

1.49

25.07

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

640

2667

1.58

24.75

1.2

163.8

201.2

titre

0.57

106

449

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

419

1562

1.77

24.68

1.1

8.6

10.6

u/ml

0.57

276

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

648

2713

1.57

24.57

2.9

2.7

—

(3014271) Vancomycin [Susceptibility]

365

1310

1.83

24.36

3.2

2.8

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

637

2662

1.58

24.35

1.2

258.5

176.5

titre

0.35

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

224

675

2.18

24.24

1.7

2.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

316

1084

1.92

24.21

1.3

1.2

110.3

111.3

0.25

283

969

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1090

5095

1.41

24.07

2.8

2.9

1594.2

6278.2

u/ml

0.95

291

(3030905) Polymorphonuclear cells [#/volume] in Blood

1383

6730

1.36

23.97

3.4

3.3

4.2

4.1

e9/l

0.86

1377

6719

(3017569) Oxygen content in Arterial blood

345

1223

1.86

23.94

2.3

2.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

603

2502

1.59

23.77

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

603

2502

1.59

23.77

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

603

2502

1.59

23.77

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1944

9956

1.29

23.54

1.4

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

200

586

2.25

23.17

1.6

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

458

1786

1.69

23.06

1.2

26.0

23.1

u/l

0.51

396

1540

(3004616) Nuclear Ab [Presence] in Serum

871

3938

1.46

23.06

1.4

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

332

1178

1.86

23.00

1.3

1.2

0.3

g/l

0.86

265

935

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

593

2475

1.58

22.83

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

663

2839

1.54

22.82

2.3

2.1

43.0

40.8

0.66

365

(3011412) CD3 cells [#/volume] in Blood

725

3166

1.51

22.79

2.5

2.4

1.3

1.1

e9/l

2.35

416

1903

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

467

1844

1.67

22.46

1.2

99.9

86.9

u/l

1.39

413

1616

(3011048) Pyruvate [Moles/volume] in Blood

149

3.62

22.40

1.4

87.0

72.8

umol/l

2.28

135

(3010015) Selenium [Moles/volume] in Serum or Plasma

106

229

3.04

22.30

2.1

2.0

1.3

umol/l

0.59

205

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

505

2039

1.63

22.29

2.0

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

550

2277

1.59

21.94

2.6

2.5

534.5

529.3

e6/l

0.07

457

1908

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1046

4939

1.40

21.85

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1056

4995

1.39

21.83

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

891

4090

1.44

21.80

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

551

2286

1.59

21.79

2.8

2.3

—

(3023419) Bacteria identified in Sputum by Culture

790

3547

1.47

21.71

2.4

2.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

275

936

1.93

21.62

1.1

—

(3001556) Androgen free Index in Serum or Plasma

140

360

2.56

21.52

1.4

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

230

740

2.04

21.16

1.1

1.3

—

(3019977) pH of Arterial blood

399

1537

1.71

21.06

3.0

2.4

7.4

0.38

117

550

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

231

746

2.04

21.04

1.1

1.3

96.8

92.1

1.58

226

736

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1500

7536

1.31

20.99

1.1

1.4

1.8

u/ml

0.81

668

3016

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

131

330

2.61

20.98

2.3

3.3

40.9

42.2

umol/l

0.27

115

281

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

665

2906

1.51

20.89

1.7

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

476

1927

1.63

20.83

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1319

6513

1.34

20.82

1.5

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

235

767

2.02

20.81

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

237

777

2.01

20.74

1.1

—

(3051651) Icteric interference index of Serum or Plasma

451

1804

1.65

20.69

4.2

3.9

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1432

7165

1.32

20.64

2.4

120.5

106.7

ug/min

0.45

828

4331

(4146454)

690

3053

1.49

20.43

2.7

2.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

236

777

2.00

20.42

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1462

7354

1.31

20.29

1.6

1.7

11830.3

13645.8

e6/l

0.87

1037

5393

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

173

505

2.25

20.29

1.4

1.5

0.3

0.2

nmol/l

0.28

131

376

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

223

722

2.03

20.20

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

247

830

1.96

20.19

3.1

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

247

830

1.96

20.19

3.1

2.4

—

(44790049)

748

3374

1.46

20.12

1.6

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

128

326

2.58

20.09

1.1

—

(44806118)

748

3375

1.46

20.09

1.6

1.5

—

(44790047)

748

3375

1.46

20.09

1.6

1.5

—

(44790048)

748

3376

1.46

20.06

1.6

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

126

320

2.59

19.90

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

527

2215

1.57

19.78

2.6

2.5

0.2

e9/l

1.28

452

1912

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

235

782

1.98

19.76

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1355

6777

1.32

19.61

1.1

5.4

5.9

u/ml

0.45

732

3489

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

806

3709

1.43

19.52

1.1

96.3

95.8

0.19

752

3477

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

446

1814

1.62

19.21

2.9

2.7

39.8

39.3

0.16

136

626

(3051611) Lipemic interference index of Serum or Plasma

703

3172

1.46

18.92

3.7

3.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

156

453

2.26

18.57

1.1

1.0

80.1

82.6

ug/l

0.27

132

367

(4268621)

776

3588

1.43

18.35

2.4

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

327

1242

1.73

18.24

3.2

2.8

—

(3011897) Casein IgE Ab [Units/volume] in Serum

171

524

2.15

17.92

1.1

1.2

2.3

7.2

u/ml

0.68

121

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

223

755

1.94

17.92

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1280

6437

1.31

17.86

1.1

0.9

1.2

u/ml

0.86

578

2698

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

398

1614

1.62

17.41

1.6

2.0

133.9

142.2

1.48

371

1526

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

170

530

2.11

17.09

1.4

1.5

5.4

5.9

nmol/l

0.78

160

508

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

720

3329

1.43

17.07

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

749

3490

1.41

17.01

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

163

503

2.13

16.83

1.8

2.3

1.2

mmol/l

0.05

155

480

(3030313) Adrenal Ab [Titer] in Serum

116

309

2.47

16.73

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1831

9714

1.24

16.63

3.5

3.1

0.3

u/ml

0.56

1030

5512

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

603

2710

1.47

16.63

3.9

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

154

468

2.16

16.52

1.8

2.3

1.2

mmol/l

0.11

147

447

(3039000) Anion gap in Blood

1309

6684

1.29

16.34

8.0

6.5

11.3

11.2

mmol/l

0.13

1193

6012

(3044941) Cell count panel - Synovial fluid

968

4737

1.35

16.34

1.4

—

(3018572) Chloride [Moles/volume] in Blood

1309

6685

1.29

16.33

8.0

6.5

104.9

105.2

mmol/l

1.26

1193

6014

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

163

510

2.10

16.27

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

297

1136

1.72

16.23

1.1

94.5

90.3

1.35

121

551

(3029075) Extractable nuclear Ab panel - Serum

259

954

1.79

16.11

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

144

3.19

16.06

1.2

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

344

1375

1.65

15.98

1.9

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

596

5573

0.70

15.90

3.4

2.4

13.2

13.1

0.54

590

5503

(1175426) CD3 cells/100 lymphocytes in Blood

565

2531

1.47

15.87

2.1

2.0

75.0

72.7

3.65

539

2440

(3032057) Clostridioides difficile [Presence] in Stool

180

591

2.00

15.84

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

137

405

2.22

15.74

1.1

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

992

4906

1.33

15.63

2.9

3.3

1.4

1.5

0.22

756

3809

(4034850)

1926

10348

1.23

15.59

11.4

8.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

152

471

2.12

15.57

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

525

2340

1.48

15.16

2.2

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

1370

7112

1.27

15.04

2.2

2.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

506

2244

1.48

14.98

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

366

1512

1.59

14.94

38.6

36.0

7.4

ug/l

0.37

341

1375

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

553

2498

1.46

14.93

2.1

2.0

12.6

14.2

2.04

276

1172

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

512

2280

1.48

14.86

1.6

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

296

1161

1.68

14.82

1.1

1.2

116.4

107.2

3.27

273

1044

(3022621) pH of Urine by Test strip

3702

21168

1.16

14.81

3.2

2.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

233

2.60

14.75

1.5

1.3

14.4

12.8

pmol/l

0.20

195

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

473

2077

1.50

14.71

2.7

3.4

107.4

129.5

nmol/l

0.85

457

2047

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

890

4376

1.34

14.62

2.5

2.8

167.7

786.5

u/ml

1.45

850

4159

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1238

6374

1.28

14.55

1.1

2.2

2.3

u/ml

0.08

323

1594

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

299

1183

1.66

14.50

1.6

2.0

152.4

165.7

1.47

281

1120

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

475

2094

1.49

14.50

1.2

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

291

1144

1.67

14.46

2.5

2.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

182

621

1.93

14.42

1.1

0.8

3.0

umol/24h

0.47

321

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1646

8775

1.24

14.37

2.8

3.4

35.1

44.2

mg/l

2.15

1303

7111

(3034860) Kappa light chains.free [Mass/volume] in Serum

1648

8788

1.24

14.35

2.8

3.4

47.1

67.2

mg/l

1.38

1308

7117

(3035947) Staphylolysin Ab [Units/volume] in Serum

371

1553

1.57

14.35

1.1

3.6

3.9

iu/ml

0.21

133

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

442

1926

1.51

14.28

1.6

5.7

6.5

u/l

0.34

208

947

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

433

1883

1.51

14.12

1.4

—

(3002619) Bacteria identified in Specimen by Culture

179

614

1.92

13.98

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1092

5572

1.29

13.79

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

282

1116

1.66

13.70

1.1

97.3

91.2

1.54

116

545

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

112

323

2.28

13.70

2.0

2.7

0.9

1.4

mmol/l

1.30

227

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1597

8532

1.24

13.69

2.8

3.4

6.2

3.2

ratio

0.37

140

660

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

424

1853

1.51

13.54

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

650

3082

1.39

13.47

3.6

4.9

62.8

118.1

u/ml

1.84

165

987

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

339

1411

1.58

13.47

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

538

2468

1.44

13.45

1.2

1.3

0.8

1.3

u/ml

1.38

237

1080

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

542

2490

1.43

13.44

1.2

70.6

68.0

u/ml

0.07

115

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

339

1412

1.58

13.43

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

554

2559

1.43

13.34

1.2

55.1

50.8

u/ml

0.09

122

(3008757) Leukocyte morphology finding [Identifier] in Blood

681

3261

1.38

13.31

3.3

3.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

629

2977

1.39

13.19

2.8

3.3

58.5

58.3

0.09

388

1934

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

541

2498

1.43

13.07

1.2

51.1

44.8

u/ml

0.24

180

(3012494) Peanut IgE Ab [Units/volume] in Serum

260

1022

1.67

12.99

1.1

2.1

16.3

u/ml

0.84

151

576

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

794

3910

1.34

12.98

1.2

1.1

2.0

2.1

iu/ml

0.03

(40761539) Cells [Type] in Urine sediment by Light microscopy

208

768

1.78

12.96

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

244

947

1.69

12.79

2.2

2.0

149.7

787.3

e6/l

1.45

141

507

(3010503) CD19 cells [#/volume] in Blood

437

1946

1.48

12.77

2.7

2.5

0.2

0.3

e9/l

0.48

422

1900

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

309

1276

1.59

12.73

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

296

1210

1.61

12.71

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

104

304

2.25

12.38

1.2

—

(3020491) Glucose [Moles/volume] in Blood

526

2442

1.42

12.36

1.9

1.7

7.0

6.6

mmol/l

2.18

394

1808

(3006245) CD3-CD19+ cells/100 cells in Blood

309

1287

1.58

12.30

2.2

2.1

9.0

10.6

1.71

290

1194

(3014148) Varicella zoster virus Ab [Titer] in Serum

950

4845

1.29

12.11

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

986

5063

1.28

11.93

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

314

2.20

11.87

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1513

8168

1.22

11.80

1.4

—

(3021788) Differential panel - Synovial fluid

1092

5687

1.27

11.79

1.5

—

(3036603) Volume of Urine

460

2103

1.44

11.79

1.6

1.7

1961.8

1935.8

0.09

482

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

512

2397

1.41

11.52

1.2

11.4

9.6

u/ml

0.12

159

(3001964) Herpes simplex virus Ag [Presence] in Specimen

241

964

1.64

11.35

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

196

743

1.73

11.25

1.1

1.3

112.3

107.2

1.43

179

708

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

269

1109

1.60

11.23

2.1

61.5

60.4

ug/l

0.07

264

1082

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

190

716

1.74

11.13

1.3

1.2

463.0

292.5

pmol/l

1.06

126

542

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

298

1263

1.55

11.06

2.1

2.0

28.8

29.4

0.29

281

1199

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

338

1474

1.51

11.02

1.2

—

(3002256) Pathology report gross observation

7032

42512

1.10

10.91

1.2

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

133

452

1.93

10.81

2.6

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

470

2194

1.41

10.79

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1050

5505

1.26

10.76

1.1

19.2

11.2

au/ml

1.32

391

(3018851) Theophylline [Moles/volume] in Serum or Plasma

218

2.38

10.76

1.6

1.7

49.0

45.8

umol/l

0.35

218

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

188

714

1.73

10.74

1.1

1.2

93.0

88.0

0.55

213

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

164

599

1.80

10.69

1.1

1.8

5.6

u/ml

1.29

120

411

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

203

2.43

10.65

1.1

7.8

9.9

u/l

0.61

203

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

304

2.14

10.55

2.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.75

10.54

1.6

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

399

1816

1.45

10.54

2.4

2.5

846.9

1067.6

u/ml

1.02

394

1795

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

297

1273

1.53

10.52

1.1

969.5

494.5

ng/l

0.27

301

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

352

1565

1.48

10.48

1.1

99.4

96.8

0.83

278

1251

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

243

995

1.61

10.47

3.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3043

17598

1.14

10.41

2.7

3.2

52.8

49.1

u/ml

0.14

2919

17012

(4024509)

583

2839

1.35

10.38

1.7

1.5

—

(3051339) Copper [Moles/volume] in Blood

147

2.68

10.38

1.4

1.2

16.7

16.5

umol/l

0.09

127

(3006270) Folate [Moles/volume] in Blood

533

2560

1.37

10.36

1.2

375.2

374.4

nmol/l

0.03

457

2184

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

464

2180

1.40

10.30

1.1

8.4

8.2

iu/ml

0.07

597

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

381

1727

1.45

10.29

1.2

1.3

489.4

463.6

titre

0.03

126

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

168

1862

0.59

10.25

1.2

1.3

—

(3028433) Virus identified in Specimen by Culture

251

1042

1.58

10.23

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

362

1629

1.46

10.16

8.7

5.4

651.3

3757.3

u/ml

0.77

112

294

(3042631) Mycobacterium sp identified in Specimen

763

3880

1.29

10.05

2.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

371

1682

1.45

10.03

1.2

1.3

61.9

78.7

titre

0.44

143

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

149

541

1.81

9.94

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

218

882

1.63

9.89

1.6

9.4

9.0

ug/l

0.61

218

882

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1888

14470

0.85

9.86

1.9

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

220

2.30

9.76

1.2

18.2

14.9

nmol/l

0.44

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

697

3516

1.31

9.76

2.8

3.3

5.0

7.3

nmol/l

0.71

671

3411

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

184

715

1.69

9.74

1.1

1.2

77.0

76.8

0.01

204

(3027231) Wheat IgE Ab [Units/volume] in Serum

181

701

1.70

9.70

1.0

1.1

2.1

u/ml

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

426

1994

1.41

9.69

1.3

1.5

24.3

24.1

u/ml

0.02

393

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

110

364

1.99

9.69

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

361

1642

1.45

9.62

1.6

1.4

—

(3037756) Immunofixation for Serum or Plasma

1089

5815

1.23

9.53

1.5

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

308

1362

1.49

9.48

3.9

5.3

732.4

2955.1

mg/l

1.78

219

971

(3047007) Chlamydophila sp Ab [Presence] in Serum

969

5112

1.25

9.48

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

262

1122

1.54

9.38

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

251

2.17

9.25

2.7

4.3

2.1

2.4

mg/l

0.88

215

(3024869) Neuronal Ab [Presence] in Serum

140

511

1.80

9.23

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

585

2905

1.33

9.20

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

165

635

1.71

9.09

1.3

86.4

77.9

mu/l

0.16

124

475

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

341

1553

1.44

9.06

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

341

1553

1.44

9.06

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

341

1553

1.44

9.06

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

1216

6606

1.21

9.02

2.8

3.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

806

4193

1.27

8.92

2.4

2.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

459

2209

1.37

8.90

1.1

ratio

0.40

141

800

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

277

2.09

8.89

1.1

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

256

1105

1.52

8.87

1.2

0.9

0.5

g/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

704

3605

1.29

8.86

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

340

1557

1.44

8.79

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

346

1591

1.43

8.75

1.1

85.8

85.4

u/l

0.03

259

1287

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

880

4638

1.25

8.72

1.2

1.3

30.7

34.8

u/l

0.52

771

4049

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

116

407

1.87

8.68

1.4

1.3

—

(3042733) HLA Ab [Presence] in Serum

268

1174

1.50

8.68

4.8

5.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

170

2.40

8.65

1.5

2.1

9.1

8.2

nmol/l

0.04

160

(40768441) Liver Pathology biopsy report

480

2340

1.35

8.59

1.5

1.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

135

2.58

8.59

1.0

0.2

0.1

u/ml

0.35

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

345

1593

1.42

8.55

1.1

24.4

24.8

u/l

0.03

249

1242

(3000034) Microalbumin [Mass/volume] in Urine

555

2768

1.32

8.52

3.1

2.9

43.3

57.8

mg/l

0.86

400

1969

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.33

8.50

1.0

1.1

242.6

435.9

pmol/l

0.98

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

252

2442

0.68

8.46

1.2

1.3

1.5

g/l

0.06

127

(3006576) Bicarbonate [Moles/volume] in Blood

238

1024

1.53

8.40

5.6

6.3

25.1

mmol/l

0.09

222

923

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

106

366

1.90

8.34

1.0

0.1

0.3

u/ml

1.85

215

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

118

2.67

8.33

1.1

699.4

316.7

u/l

0.67

102

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

754

3928

1.26

8.29

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

569

2861

1.31

8.25

1.3

1.4

94405.0

105601.5

e6/l

0.18

395

1958

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

127

2.59

8.17

1.6

1.5

0.1

0.2

u/l

0.39

(3020123) Porphyrins [Interpretation] in Serum or Plasma

179

2.31

8.16

1.2

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

217

2.18

8.14

1.0

0.5

u/ml

0.04

118

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

159

2.40

8.12

1.5

1.7

189.7

179.1

ug/g

0.17

139

(4015189)

184

752

1.61

8.12

2.9

2.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

319

1.96

8.12

1.0

0.3

1.1

u/ml

0.97

229

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.59

8.08

1.0

0.0

0.1

u/ml

0.57

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

170

686

1.63

7.91

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.15

7.81

1.0

0.4

0.6

u/ml

0.47

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

142

549

1.70

7.77

2.7

2.5

41.4

52.4

mg/l

0.33

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

368

1751

1.38

7.73

1.6

1.7

1.9

2.5

u/field

1.20

277

1256

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

268

1207

1.46

7.64

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

268

1208

1.46

7.61

2.0

2.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

274

1.99

7.47

1.7

1.6

2.4

1.6

mg/l

0.66

171

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

306

1.93

7.46

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1324

10189

0.85

7.39

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

618

1.64

7.36

1.4

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

127

485

1.72

7.29

1.1

0.2

0.3

u/ml

0.32

293

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

974

5295

1.21

7.28

1.1

2.5

2.9

u/ml

0.64

343

2740

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

270

1230

1.44

7.28

2.0

2.1

—

(3003694) ABO and Rh group [Type] in Blood

15944

100563

1.05

7.23

1.5

—

(3049717) Cytology report of Urine Cyto stain

1853

10637

1.15

7.19

2.3

2.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

187

793

1.55

7.13

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

119

450

1.74

7.09

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

132

514

1.69

7.09

2.8

2.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

141

559

1.66

7.08

2.7

2.3

7.0

7.5

mmol/l

0.66

340

(3036071) Salmonella sp Ab [Titer] in Serum

248

1119

1.46

7.05

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

491

1.70

7.00

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1089

8473

0.84

6.97

1.4

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

113

425

1.75

6.87

1.3

1.4

45.4

53.0

0.73

216

(3020876) Protein [Mass/time] in 24 hour Urine

493

2501

1.30

6.80

1.9

2.0

1.1

1.0

g/24h

0.08

154

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

715

1.56

6.75

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

396

1951

1.33

6.73

1.4

5.7

5.6

mmol/l

1.37

375

1843

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

187

2.14

6.70

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1138

6329

1.18

6.68

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

2.44

6.63

1.0

0.1

u/ml

0.45

(3033942) Copper [Moles/time] in 24 hour Urine

142

2.31

6.57

1.2

0.9

0.8

umol/24h

0.11

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

644

3392

1.25

6.56

1.3

1.4

12.2

11.7

mmol/l

0.66

214

721

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

263

1219

1.42

6.51

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

293

1385

1.39

6.49

1.1

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

247

1133

1.43

6.48

1.0

10.3

11.5

u/ml

0.18

144

(3010375) cycloSPORINE [Mass/volume] in Blood

312

1491

1.38

6.47

27.4

27.9

118.2

116.9

ug/l

0.07

247

1252

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.88

6.42

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

331

1601

1.36

6.38

1.6

1.5

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

170

2.16

6.32

1.1

40.9

87.4

u/l

0.67

137

(3010838) Calcium [Moles/time] in 24 hour Urine

320

1542

1.36

6.32

1.6

5.4

5.6

mmol/24h

0.10

127

(3044927) Protein electrophoresis panel - Urine

523

2702

1.27

6.30

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

346

1689

1.35

6.29

1.1

1.2

21.0

10.8

u/ml

0.42

173

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

238

1091

1.43

6.28

1.9

1.6

59900.4

18874.5

u/ml

0.41

134

(3003129) Base excess in Capillary blood by calculation

167

712

1.54

6.28

1.7

1.6

1.1

0.5

mmol/l

1.09

157

670

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

2.2

1.9

mg/l

0.12

176

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

1.4

1.3

mg/l

0.06

163

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

3.7

4.0

mg/l

0.13

169

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

2.7

2.6

mg/l

0.06

191

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

2.2

mg/l

0.04

185

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

1.8

mg/l

0.03

191

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

1.9

2.2

mg/l

0.15

194

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

0.6

0.9

mg/l

0.59

177

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

270

1.90

6.22

1.7

1.6

2.2

1.8

mg/l

0.22

159

(3014133) Dog dander IgE Ab [Units/volume] in Serum

998

5527

1.19

6.19

1.1

6.1

4.2

u/ml

0.94

417

2180

(3004451) EKG impression Narrative

289

1377

1.38

6.13

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

301

1446

1.37

6.08

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

119

472

1.66

6.04

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

331

1616

1.35

6.04

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

340

1667

1.34

6.03

1.1

1683.4

1483.3

miu/ml

2.25

340

1667

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

200

2.04

6.03

1.0

0.4

0.6

u/ml

0.36

181

(3023430) Cat dander IgE Ab [Units/volume] in Serum

937

5179

1.19

5.96

1.1

6.6

4.9

u/ml

0.98

429

2150

(3016228) CD19 cells/100 cells in Blood

274

1301

1.38

5.95

2.1

2.0

9.1

8.4

0.58

266

1273

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

210

2.00

5.95

1.0

0.4

2.1

u/ml

1.34

164

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

381

1905

1.32

5.91

1.2

—

(3012565) Volume of 24 hour Urine

330

1618

1.34

5.87

1.9

2.2

1987.7

1992.4

0.02

296

1453

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

364

1812

1.32

5.84

1.6

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

107

417

1.69

5.82

1.7

1.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

325

1.78

5.77

1.0

0.3

1.6

u/ml

1.08

235

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

177

2.08

5.76

1.1

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

268

1276

1.38

5.75

2.1

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.36

5.65

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

210

1.97

5.63

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

967

5388

1.18

5.63

1.1

1.2

—

(3024263) Appearance of Synovial fluid

323

1591

1.33

5.59

1.6

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

311

1524

1.34

5.58

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

291

1414

1.35

5.52

2.2

2.1

69.0

105.0

ug/min

0.67

327

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

306

1.78

5.49

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

317

1.76

5.42

1.1

1.7

2.9

umol/24h

0.48

317

(3010370) Gastrin [Moles/volume] in Serum or Plasma

121

500

1.59

5.28

1.7

1.8

75.0

50.5

pmol/l

0.29

423

(3034426) Prothrombin time (PT)

246

1175

1.38

5.22

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

189

1.98

5.20

1.1

1.0

—

(3016750) Collection duration of Urine

352

1776

1.30

5.18

2.3

2.2

511.2

498.7

min

1.60

258

1345

(3013945) Hepatitis B virus e Ab [Presence] in Serum

194

1.96

5.17

1.3

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

289

1.77

5.11

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

232

1.87

5.10

1.3

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

177

2.00

5.09

1.1

1.2

u/field

0.51

121

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

358

1.69

5.09

1.0

0.2

0.5

u/ml

0.89

190

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1360

7843

1.14

5.07

1.4

106.6

129.0

pmol/l

1.41

1320

7648

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

304

1510

1.32

5.02

2.1

2.2

23.1

203.5

ug/l

1.79

285

1447

(3027974) Hepatitis B virus e Ag [Presence] in Serum

201

1.93

5.01

1.3

1.5

—

(40759632) Porphyrins [Mass/mass] in Stool

3.89

5.01

1.2

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

229

1.86

5.00

1.3

1.5

41.9

37.4

0.33

160

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

365

1.67

4.99

1.0

0.7

3.2

u/ml

0.74

189

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

592

1.52

4.96

4.9

5.6

—

(3022689) Creatine [Moles/volume] in Urine

190

877

1.42

4.94

1.4

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

175

1.99

4.92

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

219

1041

1.38

4.83

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

273

1344

1.34

4.82

2.5

2.7

162.1

147.5

au/ml

0.18

178

(3024932) HLA-DR beta [Type]

239

1153

1.36

4.81

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

237

1.83

4.81

1.0

0.1

0.9

u/ml

0.92

149

(3038177) Helicobacter pylori Ab [Presence] in Serum

1041

5916

1.16

4.80

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

554

2979

1.22

4.80

1.5

1.6

29.8

32.1

0.74

332

1876

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

158

709

1.46

4.78

1.5

1.6

0.4

ug/l

0.29

105

470

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

488

2594

1.24

4.73

1.7

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

336

1.68

4.72

1.0

0.4

0.5

u/ml

0.11

187

(3006442) Creatine [Moles/volume] in Serum or Plasma

444

2344

1.25

4.59

1.8

1.4

62.5

71.2

umol/l

1.63

198

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

103

425

1.59

4.59

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

203

1.88

4.59

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

285

1.73

4.56

1.2

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

9.85

4.54

2.1

2.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

345

1.66

4.54

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

117

500

1.54

4.49

1.1

2.4

6.7

pmol/l

0.69

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.80

4.47

1.4

1.3

66.5

51.3

e6/l

0.11

(3024471) HLA-A [Type]

241

1179

1.34

4.47

1.0

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

201

1.86

4.42

1.3

1.6

12.9

12.7

0.02

151

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

264

1312

1.32

4.41

3.7

3.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

281

1409

1.31

4.41

1.4

1.5

—

(3045462) Protein/Creatinine [Ratio] in Urine

293

1.70

4.40

3.5

4.8

35.6

50.2

g/mol

0.65

263

(3051593) INR in Capillary blood by Coagulation assay

255

1264

1.33

4.34

5.5

10.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

231

1129

1.34

4.33

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

7.30

4.32

1.1

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.67

4.31

1.5

2.7

3.0

2.1

mu/l

0.37

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

622

3422

1.20

4.31

1.1

—

(3000012) Reticulocyte production index

314

1604

1.29

4.30

1.4

1.5

—

(3013762) Body weight Measured

121

2.12

4.29

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

1409

1.31

4.29

1.4

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

351

1.63

4.27

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

291

1477

1.30

4.20

3.1

3.3

7.9

8.2

mg/l

0.29

228

1187

(3012898) Urea [Moles/volume] in Urine

323

1.65

4.17

1.5

1.6

157.8

173.1

mmol/l

0.53

287

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.05

4.16

1.1

1.0

17.7

13.5

umol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2044

12225

1.10

4.12

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1357

7939

1.13

4.12

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

983

5636

1.15

4.09

1.3

3.0

3.8

ug/l

4.02

874

5083

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

237

1175

1.33

4.06

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

204

1.80

3.97

1.0

18.7

19.0

u/ml

0.02

168

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.19

3.96

1.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

171

1.88

3.96

1.2

1.4

0.6

1.9

2.21

120

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

789

4465

1.16

3.94

1.0

0.5

u/ml

0.15

189

918

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

187

899

1.37

3.94

2.2

1.8

7906.9

12131.3

e6/l

0.38

100

481

(3016273) Islet cell 512 Ab [Units/volume] in Serum

239

1.73

3.91

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

207

1014

1.34

3.87

2.1

1.9

—

(40768446) Kidney Pathology biopsy report

270

1375

1.29

3.84

1.8

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

419

1.54

3.82

1.1

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

105

2.13

3.82

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.30

3.77

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

131

597

1.44

3.76

1.2

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

1085

0.69

3.76

3.1

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

1084

0.69

3.74

6.1

6.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

161

1.88

3.71

1.1

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

190

927

1.35

3.67

1.3

1.4

51.6

54.7

0.49

160

795

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

255

1.67

3.61

1.3

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

192

1.78

3.57

1.1

5.0

4.8

u/ml

0.01

158

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

401

2161

1.22

3.53

1.9

1.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.55

3.51

1.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

169

1.83

3.51

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

155

1.86

3.50

1.2

11.4

21.8

u/ml

—

(40757373) Influenza virus identified in Isolate

128

591

1.42

3.46

1.7

1.6

—

(44806071)

103

456

1.48

3.46

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

142

1.90

3.43

1.3

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

699

3968

1.16

3.41

1.5

1.6

57.8

55.8

0.59

426

2556

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

372

1998

1.22

3.40

1.4

12.1

12.6

u/l

0.72

363

1929

(3023487) Leukocytes [#/volume] in Peritoneal fluid

204

1020

1.31

3.38

2.3

1.9

3649.7

3445.6

e6/l

0.03

134

700

(3002331) Protein [Mass/volume] in Peritoneal fluid

133

623

1.40

3.34

1.4

24.1

28.7

g/l

1.03

486

(40762365) Oxygen content in Arterial blood by calculation

108

487

1.46

3.33

4.0

2.8

14.6

14.9

ml/dl

0.59

455

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1528

11016

0.91

3.26

1.4

1.6

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.72

3.21

1.0

0.1

0.2

u/ml

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

133

1.88

3.12

1.1

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

101

2.02

3.10

1.0

201.8

213.4

pmol/l

0.09

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

310

1653

1.23

3.08

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.09

3.07

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

106

1.98

3.07

1.0

1.1

0.2

g/l

0.06

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

411

1.47

3.01

1.0

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

223

1.65

3.01

1.2

1.1

30.0

21.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

100

455

1.44

2.98

2.1

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

111

515

1.42

2.98

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

519

2919

1.17

2.93

1.4

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

185

1.70

2.91

1.3

1.4

23.9

22.1

mmol/l

1.27

122

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.66

2.91

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

106

491

1.42

2.89

5.9

5.0

53.4

44.4

ug/min

0.58

381

(3000330) Specific gravity of Urine by Test strip

2505

15368

1.07

2.87

3.6

3.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.35

2.87

1.2

1.1

2.2

2.6

0.40

(3013637) Mi-2 Ab [Presence] in Serum

153

754

1.33

2.87

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

153

754

1.33

2.87

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

153

754

1.33

2.87

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

153

754

1.33

2.87

1.1

—

(3045177) Copper [Moles/volume] in Urine

2.46

2.85

1.1

0.2

0.5

umol/l

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

100

460

1.43

2.84

1.4

6.8

250135.7

nmol/l

2.77

389

(3004775) Volume in Urine collected for unspecified duration

428

2386

1.18

2.72

2.4

2.3

710.0

670.9

1.00

309

1647

(3008536) Aspergillus sp Ab [Presence] in Serum

127

614

1.36

2.72

2.3

2.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

111

525

1.39

2.71

1.2

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.10

2.70

7.5

8.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

734

5441

0.88

2.69

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.99

2.66

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

171

867

1.30

2.65

1.8

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

332

1.48

2.62

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

445

2501

1.17

2.58

1.9

2.0

2.2

2.3

u/field

0.03

231

1101

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

271

1456

1.22

2.58

1.2

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

393

1.44

2.56

2.4

2.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

420

2352

1.17

2.55

1.0

1.1

0.6

2.7

u/ml

1.62

157

635

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

158

1.70

2.53

12.9

9.3

557.8

221.9

e6/l

0.46

114

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

124

1.80

2.52

1.3

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

156

788

1.30

2.51

1.1

1.2

—

(3018133) Calcium [Moles/volume] in Urine

111

533

1.37

2.51

1.5

2.0

2.5

2.7

mmol/l

0.51

102

477

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.96

2.48

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.09

2.47

7.7

8.5

48.8

43.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

257

1.53

2.46

1.5

1.3

1.5

ml/s/173m2

0.20

163

(3026692) Albumin [Mass/volume] in Peritoneal fluid

143

718

1.31

2.42

1.6

1.4

11.5

13.7

g/l

1.92

554

(3013293) Extractable nuclear Ab [Presence] in Serum

103

492

1.38

2.42

1.6

—

(36303858) Crystals [Presence] in Urine

2.46

2.40

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

384

1.42

2.35

2.7

3.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

242

1302

1.22

2.32

1.9

2.0

9.3

mg/l

0.04

193

1040

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

228

0.49

2.30

1.1

1.3

—

(40768793) Breast Pathology biopsy report

1216

7324

1.09

2.29

1.3

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

119

1.77

2.26

1.1

1.0

1.3

u/field

0.45

(3017400) Magnesium [Moles/volume] in Urine

2.09

2.25

1.0

1.2

2.4

2.9

mmol/l

0.37

(3009677) Dengue virus Ab [Presence] in Serum

139

1.70

2.24

1.1

1.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.23

2.24

1.1

1.0

41.0

35.8

iu/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

185

1.60

2.22

6.2

4.9

—

(3035933) Granulocytes/100 leukocytes in Blood

183

962

1.25

2.19

2.5

1.7

—

(3017704) Immunofixation for Urine

279

1532

1.20

2.19

1.5

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

423

1.38

2.19

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

2.05

2.17

1.1

1.0

61.9

57.5

mu/l

0.04

(3017461) Flecainide [Moles/volume] in Serum or Plasma

166

1.62

2.16

1.5

1.7

0.7

umol/l

0.15

128

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

391

1.39

2.15

1.7

1.6

1.7

mg/l

0.43

328

(3007147) Virus identified in Stool by Electron microscopy

3.50

2.14

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

515

2975

1.14

2.12

1.8

2.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

224

1.52

2.12

1.0

1.1

12.1

7.8

u/ml

0.61

158

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

122

1.72

2.10

5.2

5.8

15.8

17.7

mmol/l

1.18

115

(3007916) DNA double strand Ab [Titer] in Serum

421

1.37

2.09

1.4

1.3

71.8

155.9

titre

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

209

1.54

2.09

2.0

2.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.36

2.07

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

138

707

1.28

2.06

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

114

570

1.31

2.04

5.0

5.9

64.5

71.1

1.71

451

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

169

1.59

2.03

1.2

1.3

2071.8

824.1

u/l

0.37

153

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.28

2.02

1.0

1.1

49.3

20.2

umol/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

855

5106

1.10

1.99

1.3

7.3

7.0

mmol/l

1.76

630

3643

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

223

1.50

1.97

1.2

117.9

101.9

ug/l

0.27

142

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1522

9324

1.07

1.94

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

388

1.37

1.94

2.4

2.3

0.7

0.6

u/field

0.18

388

(3034891) Synovial lining cells/100 cells in Synovial fluid

279

1554

1.18

1.91

1.4

1.5

3.7

4.0

0.13

363

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

163

864

1.24

1.87

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

453

0.68

1.85

6.2

1.2

7.7

7.1

mmol/l

0.56

147

(3036670) Protein [Mass/volume] in Synovial fluid

165

877

1.24

1.85

1.3

1.2

39.0

40.2

g/l

0.51

479

(40768795) Lymph node Pathology biopsy report

437

3253

0.88

1.84

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

189

1020

1.22

1.84

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.03

1.82

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

332

1.38

1.80

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

250

1.45

1.79

1.6

1.4

—

13.3

—

(3024316) Viscosity of Plasma

144

1.60

1.78

1.8

1.6

mpas

0.22

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

208

1.48

1.75

1.4

1.3

21.1

16.4

pmol/l

0.35

175

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

334

1.38

1.75

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1822

11277

1.06

1.74

1.4

—

(3044007) Cell count panel - Peritoneal fluid

154

819

1.24

1.74

2.2

1.9

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

384

2211

1.14

1.73

1.4

28.0

32.5

nmol/l

2.43

337

2047

(3000285) Sodium [Moles/volume] in Blood

357

1.36

1.73

1.2

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1820

11272

1.06

1.71

1.4

—

(3045142) Bone marrow Pathology biopsy report

451

3332

0.89

1.71

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

269

1.42

1.71

1.0

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1732

10712

1.06

1.71

3.0

3.5

335.3

1953.0

u/ml

1.91

1450

9206

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

257

1439

1.17

1.70

3.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

253

1.43

1.69

1.2

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

4.10

1.68

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

108

900

0.79

1.67

1.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.05

1.67

1.0

8238.4

12760.2

ng/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1815

11252

1.06

1.66

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1809

11221

1.06

1.63

1.4

—

(3033799) Differential panel - Peritoneal fluid

164

886

1.22

1.62

2.2

1.9

—

(3041184) Isoniazid [Presence] in Urine

2.33

1.62

2.3

2.7

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

235

1.43

1.58

1.1

28.5

24.3

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

235

1.43

1.58

1.1

13.6

34.9

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

1052

6417

1.08

1.58

3.7

3.0

1.6

mmol/l

0.14

1028

6284

(3025315) Body weight

269

1.39

1.55

4.9

4.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

229

1282

1.17

1.55

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

148

796

1.22

1.54

1.1

1.2

288.0

495.5

titre

—

(3005033) Fetal Nuchal fold Thickness US

1475

9115

1.06

1.53

1.4

1.5

—

(4211845)

305

1749

1.15

1.51

2.9

—

(3006462) Nitrate [Presence] in Urine

279

1590

1.15

1.51

3.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1929

12031

1.05

1.47

1.4

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

195

1.45

1.46

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1475

9134

1.06

1.45

1.4

1.5

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

234

1.40

1.44

2.3

3.0

60.8

327.3

pmol/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

470

3423

0.90

1.44

1.5

1.6

8.0

7.5

mmol/l

3.74

288

2013

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

307

1.35

1.44

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.36

1.43

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

118

626

1.24

1.42

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

285

1.36

1.42

1.1

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

233

0.62

1.42

2.2

2.3

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.28

1.41

1.2

1.0

8.8

0.0

u/l

—

(3018001) Oat IgE Ab [Units/volume] in Serum

252

1.38

1.41

1.1

1.0

0.2

1.0

u/ml

0.67

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.79

1.41

1.0

3.3

0.5

u/ml

—

(3019174) dRVVT (LA screen)

321

1.33

1.37

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

436

1.28

1.37

2.6

59.9

71.4

pmol/l

0.32

379

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1201

7409

1.07

1.35

1.8

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

108

1.58

1.33

1.1

226.2

259.6

nmol/l

0.53

108

(3037556) Urate [Mass/volume] in Serum or Plasma

154

847

1.19

1.32

1.5

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

307

1.33

1.30

1.2

1.3

5.1

6.4

mmol/l

1.19

151

(3013336) Amino acids [Identifier] in Serum or Plasma

1.77

1.30

3.2

2.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

195

1.41

1.29

1.1

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

151

833

1.19

1.27

1.7

2.0

38.7

37.4

u/l

0.04

134

751

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

120

1.53

1.27

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.78

1.25

1.1

106.6

94.4

nmol/24h

0.18

(3007456) Orange IgE Ab [Units/volume] in Serum

1.66

1.25

1.1

1.0

0.1

0.2

u/ml

0.43

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.74

1.20

1.0

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

160

1.44

1.19

1.1

1.3

—

14622.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

126

690

1.20

1.17

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

126

691

1.20

1.16

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

126

692

1.20

1.14

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

111

877

0.83

1.14

1.1

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.76

1.14

1.0

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

162

1.42

1.13

1.2

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.95

1.12

1.5

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

978

6044

1.06

1.10

2.9

3.4

639.6

817.2

u/ml

0.23

872

5494

(3027570) Oxalate [Moles/time] in 24 hour Urine

213

1.36

1.10

1.4

323.1

330.4

umol/24h

0.09

213

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

487

2932

1.09

1.10

1.4

1.3

70.0

115.4

pmol/l

0.79

210

877

(3034614) HLA Ag [Interpretation]

1.62

1.10

1.4

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.99

1.07

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

215

1.34

1.05

1.0

1.1

0.3

1.2

u/ml

1.38

155

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

126

1.46

1.05

1.3

1.2

u/field

0.14

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

184

1053

1.15

1.03

1.6

1.7

131.8

130.1

au/ml

0.01

142

(3027035) Albumin [Mass/time] in 24 hour Urine

296

1.29

1.03

1.2

1.3

136.5

320.5

mg/24h

—

(3022229) Phosphate [Moles/volume] in Urine

182

1.37

1.03

1.1

2.0

20.1

20.5

mmol/l

0.04

150

(4133840)

136

1044

0.86

1.03

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

244

0.70

1.01

2.3

2.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

183

1.36

1.00

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.53

0.99

1.0

0.1

u/ml

0.10

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

141

0.61

0.99

1.0

0.8

0.2

u/ml

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

101

1.50

0.98

1.1

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

156

1.39

0.97

1.2

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.32

0.95

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.79

0.94

1.1

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

324

1.26

0.94

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3003

20322

0.97

0.93

1.7

1.6

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.19

0.92

1.3

1.2

35.8

27.8

nmol/24h

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

121

679

1.17

0.91

2.6

2.5

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.76

0.86

2.0

2.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

142

813

1.15

0.84

1.2

1.3

39.1

39.3

0.02

552

(3028468) Fragments [Presence] in Blood by Light microscopy

1.97

0.84

1.0

2.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

733

0.85

0.82

1.2

1.3

329.1

269.3

ug/l

0.10

396

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.72

0.81

1.2

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.77

0.81

1.0

—

(4094501)

1379

8692

1.04

0.80

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

273

1966

0.91

0.79

1.2

1.3

15.6

14.1

u/l

0.41

256

1803

(3017958) Strawberry IgE Ab [Units/volume] in Serum

107

1.41

0.77

1.0

0.1

0.2

u/ml

0.39

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

185

0.71

0.76

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.68

0.75

1.0

1.1

1058.2

2192.1

titre

1.43

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.73

0.75

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

568

3510

1.06

0.73

1.8

1.9

27.8

23.9

ug/l

0.46

555

3437

(4212803)

247

1.25

0.73

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

337

2045

1.08

0.73

5.8

6.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4783

30794

1.02

0.72

3.4

4.1

22.8

24.1

ug/l

0.11

3797

24458

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

126

1.36

0.71

2.0

2.9

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

330

0.80

0.71

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.43

0.70

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

121

1.36

0.69

2.0

2.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.41

0.69

3.2

3.1

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.54

0.69

1.6

2.1

7.4

16.9

ng/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

441

3091

0.94

0.68

1.4

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.55

0.68

1.2

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

1.49

0.67

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

372

2276

1.07

0.67

1.6

1.9

—

(44786800) Granulocytes/100 leukocytes in Body fluid

316

1.21

0.66

1.2

1.3

28.6

24.9

0.31

242

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.46

0.65

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

287

1.21

0.65

1.2

—

(3027874) Urate [Moles/volume] in Urine

100

1.38

0.65

1.0

1.1

1.6

7.8

mmol/l

0.52

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

123

1.33

0.64

1.3

1.1

—

(3049233) Organic acids panel - Urine

1.64

0.62

1.1

1.0

—

(3032641) Amino acids panel - Urine

1.64

0.62

1.3

1.4

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

132

0.70

0.62

1.0

0.8

0.4

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

341

2399

0.93

0.61

1.3

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

130

1.31

0.61

9.5

9.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.60

0.60

1.2

1.1

136.8

145.5

mmol/24h

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

183

1.26

0.59

1.0

1.2

—

438.6

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

1.79

0.59

1.2

1.1

137.0

71.1

umol/l

—

(40758292) HTLV I+II Ab panel - Serum

605

0.87

0.59

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

102

1.35

0.59

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.52

0.58

2.2

4.6

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

231

1.22

0.58

1.0

1.1

—

(4281824)

501

3471

0.95

0.57

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

504

0.86

0.56

5.2

5.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.63

0.55

7.8

6.6

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.52

0.55

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

191

1150

1.09

0.55

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

354

1.17

0.55

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

377

2628

0.94

0.54

1.3

6.4

6.3

mmol/l

0.50

342

2429

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.58

0.54

1.2

2.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

104

1.33

0.53

1.1

1.0

5.0

5.3

mmol/l

0.15

(21494567) Legionella sp IgM Ab [Presence] in Serum

240

1.20

0.53

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

552

1.13

0.53

1.1

1.3

39.8

174.3

titre

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

120

0.71

0.53

1.0

1.1

0.8

u/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

114

670

1.12

0.53

1.3

1.2

60.9

43.7

mg/l

0.18

477

(3015183) Erythrocyte sedimentation rate

275

1935

0.93

0.53

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

454

1.14

0.52

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

134

796

1.11

0.52

1.9

2.7

100.7

109.0

ng/l

0.30

419

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.41

0.51

1.1

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

573

3591

1.05

0.51

2.8

2.3

105.5

105.6

mmol/l

0.21

573

3558

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.41

0.51

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

489

3053

1.05

0.51

3.8

38.6

49.6

u/ml

0.60

482

3020

(40762814) Titanium [Mass/volume] in Blood

491

0.87

0.50

2.4

2.3

4.2

3.7

ug/l

0.16

171

(3003740) Influenza virus B Ag [Presence] in Specimen

912

6204

0.96

0.49

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

462

0.87

0.49

3.2

3.0

—

(3041354) Potassium [Moles/volume] in Venous blood

572

3592

1.05

0.48

2.8

2.3

4.0

mmol/l

1.31

572

3559

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

165

1.23

0.48

3.9

3.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3287

21973

0.98

0.48

1.4

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

177

1.22

0.48

1.0

0.6

9.0

u/ml

0.49

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.43

0.47

1.3

1.4

0.6

0.7

u/field

—

(3026470) Cobalt [Mass/volume] in Blood

247

1733

0.94

0.46

2.0

3.8

3.7

ug/l

0.03

210

1538

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

336

1.15

0.46

3.0

2.9

1.2

1.3

mg/l

0.20

222

(3049242) von Willebrand panel - Platelet poor plasma

107

1.29

0.46

1.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6057

40264

0.99

0.45

1.5

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

507

0.88

0.45

6.1

7.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

197

1202

1.08

0.45

2.9

3.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.31

0.44

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

203

1.20

0.44

1.6

1.7

0.7

0.07

158

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

390

2434

1.05

0.44

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

951

6049

1.03

0.44

3.9

3.1

7.5

mmol/l

0.24

930

5942

(3002523) Influenza virus A Ag [Presence] in Specimen

914

6199

0.97

0.43

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.41

0.43

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

375

2339

1.05

0.43

1.1

1.0

1.7

3.5

u/ml

0.51

114

559

(3051387) C reactive protein [Mass/volume] in Capillary blood

1094

6975

1.03

0.43

4.1

3.1

24.5

26.5

mg/l

0.99

654

4377

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

130

0.76

0.43

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

493

1.12

0.43

1.3

1.2

—

(40763590) HLA-DQ beta [Type]

126

1.25

0.43

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.42

0.43

1.1

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.38

0.42

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

192

1.20

0.42

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

150

1.23

0.42

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

137

978

0.92

0.42

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.35

0.41

3.1

4.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

753

4777

1.04

0.41

1.7

1.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.31

0.40

5.8

5.4

0.2

mmol/l

0.36

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

251

1748

0.94

0.40

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

224

1.17

0.40

3.5

4.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

200

0.82

0.39

1.0

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.43

0.39

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

154

938

1.08

0.39

1.4

56.9

62.3

1.11

130

765

(46236302) HLA-C [Type] by High resolution typing

128

1.23

0.38

1.0

—

(40768806) Pleura Pathology biopsy report

411

2820

0.96

0.38

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

586

1.10

0.37

2.3

5.3

49.9

57.3

u/l

0.24

233

(3010937) Rubella virus Ab [Presence] in Serum

232

1.16

0.37

1.1

—

(3047189) Immunofixation for 24 hour Urine

187

1309

0.94

0.36

1.7

1.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

463

0.89

0.36

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

360

2472

0.96

0.35

1.3

630.4

493.2

u/l

0.68

338

2344

(3023383) Lactate [Moles/volume] in Pleural fluid

117

832

0.92

0.35

1.3

4.7

3.3

mmol/l

2.55

109

762

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

100

1.25

0.34

1.1

856.4

4722.0

ng/l

2.22

(40758358) Immune stain study

137

1.20

0.32

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

472

1.10

0.32

1.8

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

230

0.86

0.32

4.1

5.8

—

(3001729) Color of Synovial fluid

242

1.14

0.31

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

631

1.08

0.31

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

236

1.14

0.31

1.1

4.8

17.4

iu/ml

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.31

0.31

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

676

0.92

0.30

1.5

1.4

30.7

22.7

1.52

561

(3022670) pH of Venous cord blood

1.31

0.29

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

127

1.19

0.29

1.0

—

(40760410) HLA-B [Type] by High resolution

127

1.19

0.29

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.28

0.28

1.5

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.28

0.28

1.5

1.3

—

(3022475) Manganese [Moles/volume] in Blood

214

1.14

0.27

1.1

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

358

1.10

0.27

1.4

1.5

103.3

115.6

ug/l

0.41

289

(3007542) Rye IgE Ab [Units/volume] in Serum

202

1.14

0.27

1.0

0.9

10.0

u/ml

0.46

(3025577) Chromium [Mass/volume] in Blood

246

1687

0.96

0.26

2.1

2.5

2.4

ug/l

0.10

195

1423

(3025886) Oxalate [Mass/time] in 24 hour Urine

106

0.81

0.26

1.1

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

1.24

0.25

1.4

—

(4035726)

4216

27948

0.99

0.25

1.4

—

(3035880) pH of Pleural fluid

214

1470

0.96

0.25

1.3

—

(3013862) HLA-DP [Type]

129

1.17

0.25

1.0

—

(3012441) Differential panel - Pleural fluid

417

2826

0.97

0.25

1.5

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.1

—

1.5

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.6

—

4.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.6

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

497

1.07

0.21

3.4

2.7

2000.4

1741.4

u/l

0.11

448

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

239

1512

1.04

0.21

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(4038314)

317

0.91

0.21

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.22

0.21

1.2

20.9

30.1

mg/l

1.36

(1617658) Protocol used for examination of sentinel lymph nodes

355

2401

0.97

0.21

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

126

1.15

0.20

1.7

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

137

0.86

0.20

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

538

3613

0.98

0.19

1.5

1.4

34.7

33.1

g/l

2.17

486

3244

(3023436) Glucagon [Mass/volume] in Serum or Plasma

170

1.12

0.19

1.3

1.7

238.7

193.6

ng/l

0.46

147

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

349

0.92

0.19

1.3

49.4

283.8

u/l

1.02

243

(3032868) Hemoglobin electrophoresis panel in Blood

328

1.08

0.19

1.5

1.6

—

(3013466) aPTT in Blood by Coagulation assay

227

1.10

0.19

1.1

36.0

36.3

0.12

190

(3000919) Neutrophils/100 leukocytes in Pleural fluid

114

712

1.05

0.18

1.4

26.9

21.4

1.20

106

640

(21494434) Karyotype in Bone marrow

374

2521

0.97

0.18

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

190

1.11

0.17

1.7

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

285

1.08

0.17

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

773

5162

0.98

0.17

3.7

3.5

29.0

38.6

u/ml

1.96

744

4971

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

635

0.95

0.16

2.3

1.7

2.0

3.5

ug/l

1.02

392

(3018291) Platelet Ab [Presence] in Serum

1.22

0.15

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

277

0.92

0.15

1.3

1.5

0.3

0.2

umol/l

0.60

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

106

0.87

0.15

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.17

0.14

1.2

1.5

1.8

2.2

mmol/24h

0.60

(3027456) Digoxin [Moles/volume] in Serum or Plasma

760

5062

0.99

0.14

3.2

3.1

0.8

nmol/l

0.42

559

3918

(3042301) Urate [Moles/volume] in Synovial fluid

1.18

0.14

1.0

448.2

358.0

umol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.15

0.13

1.3

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

423

0.95

0.13

1.3

1.2

1.5

mmol/l

0.27

261

(3034092) Cytoplasmic Ig cells/100 cells in Blood

482

0.95

0.12

12.6

6.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

513

0.96

0.10

1.2

1.7

mmol/l

0.02

306

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

419

0.96

0.10

8.6

8.0

0.3

0.4

umol/l

0.51

384

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.13

0.10

1.2

1.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.09

0.10

1.4

1.5

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.09

0.10

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

223

1.06

0.09

3.0

32.0

11.4

2.60

(3033705) Calcium.ionized [Moles/volume] in Venous blood

546

3544

1.01

0.09

2.9

2.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

121

1.09

0.08

1.1

1.2

0.1

g/l

0.23

(3023199) Leukocytes [#/volume] in Pleural fluid

501

3254

1.01

0.08

1.5

4782.1

3165.1

e6/l

0.79

370

2344

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.84

0.08

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2199

14508

1.00

0.07

1.4

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

124

796

1.02

0.07

1.4

3.2

2.7

0.27

108

664

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.06

0.07

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

288

0.96

0.07

1.0

1.1

22.6

20.7

u/l

0.23

190

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

135

1.07

0.07

24.7

14.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

407

0.97

0.06

1.3

1.4

11.5

11.8

0.03

209

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.90

0.06

2.1

1.4

5.8

6.6

mg/l

0.07

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

167

0.94

0.06

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

247

0.96

0.06

1.1

18.6

17.2

g/l

0.44

220

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

123

793

1.02

0.05

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

323

2142

0.99

0.05

1.0

0.5

0.7

u/ml

0.27

277

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

240

1.04

0.05

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

669

0.98

0.04

10.3

8.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

384

1.03

0.04

1.2

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1172

7677

1.00

0.02

4.8

3.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

459

1.02

0.02

1.0

—

(3048879) Bone marrow aspiration report

129

840

1.01

0.01

1.9

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

189

1234

1.01

0.01

1.8

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

225

1.02

0.01

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

450

2948

1.00

0.01

1.5

1.4

51344.8

51529.0

e6/l

0.00

277

1748

(3045788) Cell count panel - Pleural fluid

384

2515

1.00

0.01

1.6

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

175

0.98

0.00

1.1

—

(3006598) pH of Arterial cord blood

1.06

0.00

1.0

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

206

0.99

0.00

2.6

2.2

8.1

17.0

1.83

102

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

258

0.99

0.00

2.5

2.2

47.0

59.5

1.10

156

(3014891) Appearance of Pleural fluid

362

1.00

0.00

1.8

1.6

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.99

0.00

1.1

1.0

0.0

0.1

g/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.98

0.00

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

116

765

1.00

0.00

9.7

8.6

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.00

0.00

1.1

0.0

0.2

g/l

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.97

0.00

2.4

2.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

145

1.00

0.00

1.0

1.1

—

(44806420)

117

767

1.00

0.00

2.1

2.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

367

2413

1.00

0.00

1.8

4.0

3.7

mg/l

0.68

344

2301

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.02

0.00

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.02

0.00

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.02

0.00

1.3

1.1

85.6

79.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.02

0.00

2.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.02

0.00

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.02

0.00

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.02

0.00

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MOOD – Mood disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mood disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Mood disorders (KRA_PSY_MOOD)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints